<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Fibrogenesis Tissue Repair</journal-id><journal-title>Fibrogenesis &#x00026; Tissue Repair</journal-title><issn pub-type="epub">1755-1536</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19014418</article-id><article-id pub-id-type="pmc">2637833</article-id><article-id pub-id-type="publisher-id">1755-1536-1-6</article-id><article-id pub-id-type="doi">10.1186/1755-1536-1-6</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Experimental obstructive cholestasis: the wound-like inflammatory liver response</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Aller</surname><given-names>Mar&#x000ed;a-Angeles</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>maaller@med.ucm.es</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Arias</surname><given-names>Jorge-Luis</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>jarias@uniovi.es</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Garc&#x000ed;a-Dom&#x000ed;nguez</surname><given-names>Jose</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>eixil10@telefonica.net</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Arias</surname><given-names>Jose-Ignacio</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>joseignacio.arias@sespa.princast.es</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Dur&#x000e1;n</surname><given-names>Manuel</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>mduran.hflr@salud.madrid.org</email></contrib><contrib id="A6" corresp="yes" contrib-type="author"><name><surname>Arias</surname><given-names>Jaime</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>jariasp@med.ucm.es</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Surgery I, School of Medicine, Complutense University of Madrid, Spain</aff><aff id="I2"><label>2</label>Neurosciences Laboratory, School of Psychology, University of Oviedo, Asturias, Spain</aff><aff id="I3"><label>3</label>Plastic and Reconstructive Surgery Unit, Getafe Hospital, Madrid, Spain</aff><aff id="I4"><label>4</label>General Surgery Unit, Monte Naranco Hospital, Oviedo, Consejer&#x000ed;a de Salud y Servicios Sanitarios, Principado de Asturias, Spain</aff><aff id="I5"><label>5</label>Health Sciences School, King Juan Carlos University, Madrid, Spain</aff><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>3</day><month>11</month><year>2008</year></pub-date><volume>1</volume><fpage>6</fpage><lpage>6</lpage><ext-link ext-link-type="uri" xlink:href="http://www.fibrogenesis.com/content/1/1/6"/><history><date date-type="received"><day>26</day><month>5</month><year>2008</year></date><date date-type="accepted"><day>3</day><month>11</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 Aller et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2008</copyright-year><copyright-holder>Aller et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>               Aller               Mar&#x000ed;a-Angeles                              maaller@med.ucm.es            </dc:author><dc:title>            Experimental obstructive cholestasis: the wound-like inflammatory liver response         </dc:title><dc:date>2008</dc:date><dcterms:bibliographicCitation>Fibrogenesis &#x00026; Tissue Repair 1(1): 6-. (2008)</dcterms:bibliographicCitation><dc:identifier type="sici">1755-1536(2008)1:1&#x0003c;6&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1755-1536</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><p>Obstructive cholestasis causes hepatic cirrhosis and portal hypertension. The pathophysiological mechanisms involved in the development of liver disease are multiple and linked. We propose grouping these mechanisms according to the three phenotypes mainly expressed in the interstitial space in order to integrate them.</p><p>Experimental extrahepatic cholestasis is the model most frequently used to study obstructive cholestasis. The early liver interstitial alterations described in these experimental models would produce an ischemia/reperfusion phenotype with oxidative and nitrosative stress. Then, the hyperexpression of a leukocytic phenotype, in which Kupffer cells and neutrophils participate, would induce enzymatic stress. And finally, an angiogenic phenotype, responsible for peribiliary plexus development with sinusoidal arterialization, occurs. In addition, an intense cholangiocyte proliferation, which acquires neuroendocrine abilities, stands out. This histopathological finding is also associated with fibrosis.</p><p>It is proposed that the sequence of these inflammatory phenotypes, perhaps with a trophic meaning, ultimately produces a benign tumoral biliary process &#x02013; although it poses severe hepatocytic insufficiency. Moreover, the persistence of this benign tumor disease would induce a higher degree of dedifferentiation and autonomy and, therefore, its malign degeneration.</p></abstract></article-meta></front><body><sec><title>Background</title><p>Obstructive cholestasis is characterized clinically by jaundice, discolored urine, pale stools and pruritus [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>]. Obstruction of the biliary tree, either intrahepatic or extrahepatic, induces a characteristic pattern of early and late liver morphologic features that can be attributed to the evolution of an inflammatory response [<xref ref-type="bibr" rid="B3">3</xref>].</p><p>Hepatic inflammation is an important feature of cholestasis liver disease in both humans [<xref ref-type="bibr" rid="B1">1</xref>] and experimental animals [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. Inflammatory features of obstructive cholestasis include portal tract edema [<xref ref-type="bibr" rid="B3">3</xref>], neutrophil infiltration in the portal tracts [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B5">5</xref>], proliferation of the biliary epithelial cells [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B3">3</xref>] and portal tract fibrosis [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B6">6</xref>].</p><p>The preferable localization of the inflammatory response in the portal tract reflects the importance that this space occupies in the development of the hepatic cholestasis pathology. In this way, the main role of the portal tract in hepatic inflammation is similar to that of the interstitial space during inflammation of other organs or tissues [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. This is why both spaces, the portal tract and the interstitium, can be considered similar to a certain extent.</p></sec><sec><title>The functional biliary tree in the interstitial space</title><p>The biliary tree begins with the 'source of the bile', which is the bile canaliculus, made up by the canalicular domain of adjacent hepatocytes [<xref ref-type="bibr" rid="B3">3</xref>]. Bile canaliculi form a network of channels between hepatocytes and drain into the canals of Hering (intrahepatic bile ducts) that are lined by hepatocytes and cholangiocytes and also contain hepatic stem cells [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B11">11</xref>].</p><p>The canals of Hering continue into the bile ductules, which in turn drain into interlobular bile ducts, located in the portal space (Figure <xref ref-type="fig" rid="F1">1</xref>). Bile ductules and interlobular bile ducts are composed entirely of cholangiocytes. Interlobular bile ducts then continue into progressively larger ducts and finally drain into the extrahepatic biliary tract. The extrahepatic biliary tract is grossly divided into the common hepatic duct, the common bile duct, the cystic duct and the gall bladder [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B11">11</xref>]. The intrahepatic and extrahepatic biliary tract are supplied and nourished by a network of fine vessels called the peribiliary vascular (or capillary) plexus, derived from the hepatic artery [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B9">9</xref>]. The liver has a connective envelope, that inflexes at the level of the hilum and follows ducts and vessels within the organ until the periportal spaces. The periportal spaces represent the center of the functional units of the organ. From the portal tract, the blood supplies feed into vascular sinusoids that are bounded by laminae of hepatocytes that finally drain into the efferent central vein [<xref ref-type="bibr" rid="B12">12</xref>].</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Schematic 3D representation of a complex acinus according to Rappaport</bold>. Three portal tracts diverge from one axis, made up of the bile duct, the hepatic arterial and portal venous branches. At the same time, several trabeculae or laminae hepatis that are two cells thick arise from these three portal spaces and are oriented towards the efferent veins (central veins). In the lower part of the drawing, the liver plates are covered by the sinusoidal endothelium and the space of Disse located between both structures contains tissue fluid, which flows outwards into the lymphatics of the portal zones. The space of Disse continues with the portal space, and they both make up the interstitial space of the acinus.</p></caption><graphic xlink:href="1755-1536-1-6-1"/></fig><p>Between the sinusoidal endothelium and the vascular pole of the hepatocytes lies the space of Disse (perisinusoidal space) [<xref ref-type="bibr" rid="B12">12</xref>] (Figure <xref ref-type="fig" rid="F1">1</xref>). This space contains the extracellular matrix (ECM) and hepatic stellate cells (HSCs) (also referred to as Ito cells, lipocyte, perisinusoidal or fat-storing cells), and constitutes the framework of the acinus [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>].</p><p>The composition of the ECM within the liver is not homogeneous. The connective tissue of the space of Disse is different from the connective tissue of the rest of the liver, such as the external capsule, septa, periductal and perivascular areas, and portal tracts [<xref ref-type="bibr" rid="B12">12</xref>]. Thus, two types of ECM are present in the normal liver acinus, namely the ECM sinusoidal tract in the space of Disse with HSCs, and the ECM in the portal and central vein tracts, where myofibroblasts are present [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>].</p><p>Therefore, both the space of Disse and portal-central vein spaces, are considered to be interstitial spaces of the liver acinus, with the functional ability to synthesize and to degrade the ECM [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. Thus, the ECM is not only a scaffold, having a mechanical role in supporting and maintaining tissue structures, but is also a complex and dynamic meshwork influencing many biological cell functions. The ECM has profound influences on the structure, viability and function of cells. However, it has also been recognized that the effect of the ECM on cells extends to immune and inflammatory cells [<xref ref-type="bibr" rid="B16">16</xref>]. Since the biliary microcirculation moves immersed in the ECM of the liver interstitial spaces, Disse and portal spaces, it is not bold to propose that in obstructive cholestasis the liver ECM plays a key etiopathogenic role.</p></sec><sec><title>Surgical experimental cholestasis</title><p>Obstructive jaundice causes a high rate of morbidity and mortality in the human clinical field [<xref ref-type="bibr" rid="B17">17</xref>]. The serious repercussions of cholestasis on the liver and on the systemic level [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B17">17</xref>] have led to the creation of many experimental models so as to better understand its pathogenesis, prophylaxis, and treatment.</p><p>Several surgical techniques for developing extrahepatic cholestasis have been described, especially in the rat, based on the section of the bile duct between ligatures [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. These techniques are models of reversible obstructive jaundice, since they imply a high incidence of recanalization of the extrahepatic biliary route, which can be avoided by placing the duodenum and the distal part of the stomach between the two ligated and sectioned ends of the bile duct [<xref ref-type="bibr" rid="B19">19</xref>]. These macrosurgical techniques of extrahepatic cholestasis, called bile duct ligation (BDL), caused development of infected hilar biliary pseudocysts by dilation of the proximal end of the bile duct. As a result, the animals died during the first 2 weeks of the postoperative period due to sepsis caused by multiple abscesses in the intraperitoneal, hepatic and pulmonary areas [<xref ref-type="bibr" rid="B20">20</xref>-<xref ref-type="bibr" rid="B22">22</xref>].</p><p>The hepatic parenchyma in the rat has four lobes: the right lateral, middle, left lateral and caudate lobes, which in turn have independent portal and arterial vascularization and a separate biliar drainage [<xref ref-type="bibr" rid="B23">23</xref>] (Figure <xref ref-type="fig" rid="F2">2</xref>).</p><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Representation of the rat's liver made up of four lobes: median (ML), left lateral (LLL), right lateral (RLL) and caudate (CL)</bold>. In the hilum, the relation between the portal, arterial and biliary branches is appreciated, as well as the inexistence of the gall bladder. CBD, common bile duct; HA, hepatic artery; PV, portal vein.</p></caption><graphic xlink:href="1755-1536-1-6-2"/></fig><p>This anatomic feature makes it possible to resect the bile ducts that drain the four lobes of the liver in continuity with the common bile duct up to the beginning of its intrapancreatic segment by means of a microsurgical technique [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. First, the common bile duct is ligated and sectioned close to its intrapancreatic portion. This maneuver, which produces dilation of the extrahepatic biliary tract, facilitates the posterior dissection of the common bile duct and the lobular biliary branches of the four hepatic lobes.</p><p>Once the common bile duct is sectioned, it is shifted upwards. The dissection and section between ligatures of all the biliary branches that drain the hepatic lobes is possible by using a binocular operatory microscope (Zeiss, OPMI 1-FR, Oberkochen, Germany). First, the biliary branch of the caudate lobe and then the biliary branch of the right lateral lobe are dissected, ligated and sectioned close to the hepatic parenchyma (Figure <xref ref-type="fig" rid="F3">3</xref>). The upward dissection of the extrahepatic biliary tract makes it possible to individualize, ligate and section the biliary branches draining the middle lobe and, finally, the same procedure is followed with the biliary branch of the left lateral lobe [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B24">24</xref>] (Figure <xref ref-type="fig" rid="F3">3</xref>).</p><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Microsurgical technique of extrahepatic cholestasis in the rat</bold>. The common bile duct and the lobular bile ducts are sectioned between ligations. The dissection, ligation and sectioning of the lobular bile ducts must be performed without damaging either the portal or arterial vascularization of these lobes. CL, caudate lobe; LLL, left lateral lobe; ML, middle lobe; RLL, right lateral lobe.</p></caption><graphic xlink:href="1755-1536-1-6-3"/></fig><p>An advantage of the microsurgical technique of extrahepatic cholestasis in the rat is the absence of large biliary pseudocyst formation, which would explain why early mortality is not present. It is possible that the absence of the hilus pseudocyst in this microsurgical model of cholestasis decreases the incidence of hepatopulmonary infection and thus prevents mortality related to sepsis [<xref ref-type="bibr" rid="B22">22</xref>,<xref ref-type="bibr" rid="B24">24</xref>].</p><p>The macrosurgical extrahepatic cholestasis in mice consists normally in double ligation of the common bile duct with 4-0 braided silk sutures and then, sectioning between the ligatures. Finally, the cystic duct is ligated [<xref ref-type="bibr" rid="B25">25</xref>]. However, the microsurgical technique can be also applied to mice. The mouse liver, just like the rat's, is composed of four lobes, with the same names (Figure <xref ref-type="fig" rid="F4">4</xref>). The main difference is that the mouse liver has a gall bladder. That is why, if BDL is performed, it is followed by a marked dilation of the gall bladder, which may lead to perforation and choleperitoneum [<xref ref-type="bibr" rid="B25">25</xref>].</p><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>Microsurgical technique for producing extrahepatic cholestasis in mice</bold>. CBD, common bile duct with a long ligature to facilitate handling; CL, caudate lobe; D, duodenum; G, gall bladder; LLL, left lateral lobe; LM, medial lobe; RLL, right lateral lobe.</p></caption><graphic xlink:href="1755-1536-1-6-4"/></fig><p>Microsurgical extrahepatic cholestasis in the mouse also consists in the resection of the four lobular bile ducts in continuity with the common bile duct (Figure <xref ref-type="fig" rid="F4">4</xref>), but cholecystectomy must be added. The dissection, ligation and section of the bile ducts from the middle and left lateral lobes are simplified if the dissection of the gall bladder and the cystic duct is performed beforehand (Figure <xref ref-type="fig" rid="F5">5</xref>).</p><fig position="float" id="F5"><label>Figure 5</label><caption><p><bold>Cholecystectomy during the production of extrahepatic cholestasis in mice</bold>. The gall bladder is grasped with forceps near the fundus. The cystic artery is divided by caught and then the mesentery is cut with scissors (on top). The gall bladder is held in the left hand and the cystic duct is cleared of soft tissue by gentle blunt dissection. Then, the lobular bile ducts of the median and left lateral lobes (on bottom) are sectioned between ligations.</p></caption><graphic xlink:href="1755-1536-1-6-5"/></fig><p>The use of broad-spectrum prophylactic antibiotics and weekly administration of vitamin K (8 mg.kg<sup>-1 </sup>intramuscularly) has been proposed to reduce the early death of the animals [<xref ref-type="bibr" rid="B25">25</xref>-<xref ref-type="bibr" rid="B27">27</xref>]. In rats with microsurgical extrahepatic cholestasis, the weekly administration of antibiotics and vitamin K makes it possible for rodents to survive over 8 weeks.</p><p>In the long-term evolution, both macrosurgical (BDL) and microsurgical experimental cholestasis models develop hepatomegaly with a marked ductular proliferation and fibrosis, but the loss of normal liver architecture, typical of cirrhosis, is seldom found [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B28">28</xref>]. In relation to extrahepatic alterations, jaundice, choluria [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B28">28</xref>], portal hypertension with enlarged spleen and collateral portosystemic circulation [<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B27">27</xref>-<xref ref-type="bibr" rid="B30">30</xref>], hepatic encephalopathy [<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B32">32</xref>] and ascytes [<xref ref-type="bibr" rid="B27">27</xref>] stand out. Therefore, experimental extrahepatic cholestasis is not only a good model for studying the hepatic pathology related to biliary obstruction, but also for studying extrahepatic complications.</p><p>However, the aim of this review is limited to coverage of hepatic pathology related to obstructive cholestasis. The etiopathogenic mechanisms described in its production could be compared to those that play the main role in the evolution of inflammatory response related to other injuries. [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B33">33</xref>]. It is worth mentioning that in obstructive cholestasis and other inflammatory conditions, the tissue alterations mainly occur in the interstitial space. That is why their alterations and their respective production mechanisms are mainly referred to in this context.</p></sec><sec><title>The interstitial space and the inflammatory response</title><p>The interstitial space always seems to be the battlefield for inflammation, whether it is due to trauma [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B34">34</xref>], infection [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B34">34</xref>] or tumors [<xref ref-type="bibr" rid="B35">35</xref>-<xref ref-type="bibr" rid="B38">38</xref>].</p><p>The successive pathophysiological mechanisms that develop in the interstitial space of tissues when they undergo acute post-traumatic inflammation are considered increasingly complex trophic functional systems for using oxygen [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B34">34</xref>]. Although their extent is apparently different, the hypothetical similarity between local and systemic responses to mechanical injury could be attributed to a general response mechanism to injury in the body. This mechanism is based on the successive and predominant expression of the nervous, immune and endocrine pathological functions [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>].</p><p>The nervous or immediate functional system has ischemia/reperfusion and edema, which work by by diffusion through the injured tissue. This trophic mechanism has a low energy requirement that does not require oxygen (ischemia), or in some circumstances the oxygen is not correctly used, with subsequent development of reactive oxygen and nitrogen species (ROS/RNS) (reperfusion) (Table <xref ref-type="table" rid="T1">1</xref>) [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>].</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Phases of the inflammatory interstitial response</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Phase</bold></td><td align="left"><bold>Response</bold></td></tr></thead><tbody><tr><td align="left">I. Immediate or nervous</td><td align="left">Ischemia/reperfusion</td></tr><tr><td></td><td align="left">Edema</td></tr><tr><td></td><td align="left">Oxidative and nitrosative stress</td></tr><tr><td colspan="2"><hr></hr></td></tr><tr><td align="left">II. Intermediate or immune</td><td align="left">Activation of resident inflammatory cells</td></tr><tr><td></td><td align="left">Infiltration by inflammatory cells</td></tr><tr><td></td><td align="left">Toxin and bacterial translocation</td></tr><tr><td></td><td align="left">Enzymatic stress</td></tr><tr><td colspan="2"><hr></hr></td></tr><tr><td align="left">III. Late or endocrine</td><td align="left">Angiogenesis</td></tr><tr><td></td><td align="left">Cell proliferation</td></tr><tr><td></td><td align="left">Cell specialization</td></tr><tr><td></td><td align="left">Energetic stress</td></tr></tbody></table></table-wrap><p>The immune or intermediate functional system produces infiltration of the injured tissue by inflammatory cells, especially by leukocytes. The immune cell residents in the interstitial space of the affected tissues and organs are also activated. Hence the capacity of these inflammatory cells for extracellular digestion by enzyme release (fermentation) and intracellular digestion (phagocytosis) could be associated with a hypothetical trophic capacity. Improper use of oxygen persists in this immune phase. Also during this phase the lymphatic circulation continues to play an important role [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B39">39</xref>] (Table <xref ref-type="table" rid="T1">1</xref>).</p><p>During the evolution of the nervous and immune phase of the inflammatory response, the body looses its more specialized functions and structures. In this progressive deconstruction, depletion of the hydrocarbonate, lipid and protein stores occurs, as well as successive dysfunction and posterior failure, apoptosis, autophagy or necrosis of the specialized epithelium (that is, gastrointestinal, hepatic, pulmonary and renal). Although these alterations are considered a harmless consequence of the inflammatory response, they are also mechanisms through which there is a redistribution of carbohydrates, lipids and amino acids in the body. Consequently, the redistribution of metabolic resources responds to the different trophic requirements of the body as the inflammation progresses. Nevertheless, consumption of the substrate deposits and the dysfunction or failure of the specialized epithelia could also represent an accelerated process of epithelial dedifferentiation [<xref ref-type="bibr" rid="B40">40</xref>].</p><p>The hypothetical ability to involute or dedifferentiate could constitute an effective defense mechanism against injury since it could make retracing a well-known route possible, (that is, the prenatal specialization phase during the last or endocrine phase of the inflammatory response). This specialization would require or return to prominence of oxidative metabolism, and thus angiogenesis, in the affected epithelial organs, to create a capillary bed that would make regeneration of the specialized epithelial cells possible or for carrying out the repair through fibrosis or scarring [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B39">39</xref>,<xref ref-type="bibr" rid="B41">41</xref>] (Table <xref ref-type="table" rid="T1">1</xref>).</p></sec><sec><title>The liver interstitium in obstructive cholestasis</title><p>If we consider that the interstitial alterations produced during the inflammatory response are common to different conditions, the successive pathophysiological mechanisms that develop in the interstitial space of the tissues when they undergo acute traumatic inflammation [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>] would also be expressed in the liver interstitium when suffering inflammation related to obstructive cholestasis. Thus, in the experimental cholestatic obstructive inflammatory liver disease, three inflammatory phenotypes would be expressed during its evolution: the ischemia/reperfusion phenotype (nervous), the leukocyte phenotype (immune), and the angiogenic phenotype (endocrine).</p><p>The hepatic interstitium shares both biochemical and structural characteristics with other interstitial spaces of the body. The molecules secreted by the cells occupying the body tissues interact to create a complex network, which constitutes the ECM. As there are many different tissues in the body, there are also different organizations of cells and matrices [<xref ref-type="bibr" rid="B42">42</xref>].</p><p>Phylogenetic data generated from recently completed genome sequencing projects have shown that the molecules of the ECM, especially those related to cell-matrix adhesion are 'ancient and exquisitely conserved in multicellular animals' [<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B43">43</xref>]. In general, two classes of molecules are produced by the ECM: fibrous proteins (collagen, laminin and elastin) and glycosaminoglycans (GAGs) that can be non-sulfated (hialuronic acid) and sulfated [<xref ref-type="bibr" rid="B42">42</xref>]. Because of their high net negative charge, GAGs and proteoglycans play pivotal roles in biological processes, such as permeoselectivity of basement membranes, activation of chemokines and cytokines, cell-cell interactions and sequestration of growth factors [<xref ref-type="bibr" rid="B44">44</xref>,<xref ref-type="bibr" rid="B45">45</xref>]. This is the reason why their change has important implications in proinflammatory and anti-inflammatory activities [<xref ref-type="bibr" rid="B46">46</xref>-<xref ref-type="bibr" rid="B49">49</xref>].</p><p>Immediately after complete bile duct obstruction in the rat, an intense increase (60%) in biliary ductal pressure is produced [<xref ref-type="bibr" rid="B50">50</xref>] and this is quickly followed by pathological ECM changes [<xref ref-type="bibr" rid="B51">51</xref>]. By contrast, biliary decompression, by relieving mechanical stress, reverses liver lesions induced by BDL [<xref ref-type="bibr" rid="B52">52</xref>,<xref ref-type="bibr" rid="B53">53</xref>]. These experiments reflect the major importance that mechanical energy has in the etiopathogeny of liver injury in relation to biliary obstruction.</p><p>The response of the murine liver to the biliary obstructive injury implies its transcriptional reprogramming favoring the activation of genes regulating metabolism, cell proliferation and matrix remodeling in a time-restricted and sequential fashion [<xref ref-type="bibr" rid="B54">54</xref>]. Although there are a dominant activation of metabolic genes in all phases following BDL, from the immediate (1 day) to the later (21 days) phase, involvement of specific pathways varied according to the duration of obstruction [<xref ref-type="bibr" rid="B54">54</xref>]. Moreover, where some genes are upregulated, (that is, genes related to disruption of lipid metabolism and fibrosis) in the early stage of cholestasis, other genes are downregulated, (that is, genes involved in mechanisms of cell protection against the accumulation of toxic bile acids) [<xref ref-type="bibr" rid="B55">55</xref>].</p><p>The three inflammatory phenotypes hypothetically expressed in the murine liver interstitium during long-term cholestasis induced by BDL could help to integrate the etiopathogenic mechanisms that have been described. These inflammatory phenotypes would associate the genetic factors (up- and downregulated) with metabolic and histological alterations.</p></sec><sec><title>The ischemia/reperfusion phenotype</title><p>After BDL, the liver rat suffers severe hemodynamic alterations, both portal and arterial, to which the effects of ischemia/reperfusion and oxidative stress can be attributed. The increase of vascular resistance in the liver portal system related to extrahepatic cholestasis results in portal hypertension [<xref ref-type="bibr" rid="B56">56</xref>,<xref ref-type="bibr" rid="B57">57</xref>] and liver ischemia, associated with a deficient production of inducible nitric oxide synthase (iNOS) and NO [<xref ref-type="bibr" rid="B58">58</xref>].</p><p>The biliary tree is nourished by the peribiliary plexus [<xref ref-type="bibr" rid="B59">59</xref>,<xref ref-type="bibr" rid="B60">60</xref>] and around the smaller ducts the plexus gets progressively simpler and thinner [<xref ref-type="bibr" rid="B59">59</xref>]. That is why it could be assumed that the increase in intraductal pressure with bile duct dilatation in extrahepatic cholestasis could induce compression of the peribiliary plexus and, consequently bile tract ischemia. However, it has been described that after the decrease in portal vein flow, an increase in hepatic arterial blood flow or a 'hepatic arterial buffer response' is produced [<xref ref-type="bibr" rid="B61">61</xref>]. Furthermore, after 2 weeks of BDL in the rat, a significant peribiliary plexus proliferation is produced that is drained by small venules in both the portal vein branches and hepatic sinusoids [<xref ref-type="bibr" rid="B59">59</xref>]. Ischemia/reperfusion injury has been in turn involved in the pathogenesis of intrahepatic cholestasis [<xref ref-type="bibr" rid="B62">62</xref>].</p><p>Rats subjected to BDL could have excessive accumulation of hydrophobic bile acids, which are considered the main cause of hepatotoxicity [<xref ref-type="bibr" rid="B12">12</xref>]. They exhibited partial impairment of mitochondrial electron transport chain functions in the liver and oxidative stress [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B27">27</xref>]. Retention and accumulation of hydrophobic bile salts (that is, tauro- and glicochenodeoxycholate) may decrease antioxidant activities of hepatic catalase, glutathione peroxidase, reduced glutathione (GSH) and superoxide dismutase levels and induce hepatocyte necrosis by activating mitochondrial membrane permeability transition [<xref ref-type="bibr" rid="B63">63</xref>-<xref ref-type="bibr" rid="B67">67</xref>] (Figure <xref ref-type="fig" rid="F6">6</xref>).</p><fig position="float" id="F6"><label>Figure 6</label><caption><p><bold>Ischemia-revascularization and leukocytic phenotypes during the evolution of obstructive cholestasis.</bold> Predominance of oxidative stress with edema and enzymatic stress with infiltration by leukocytes and Kupffer cell activation.  AC: arterial capillar; B: bacteria; C: cholangiocyte; ECM: extracellular matrix; HSC: hepatic stellate cell; KC: Kupffer cell; LPS: lipopolysaccharide; MC: mast cell; N: Neutrophyl; PM: portal myofibroblast; PP: peribiliary arterial plexus; RBC: red blood cells; SC: stem cells; SS: sinusoidal space; Th<sub>1</sub>: T cell h<sub>1</sub>; Thi: intraepithelial lymphocyte.  </p></caption><graphic xlink:href="1755-1536-1-6-6"/></fig><p>It is accepted that there is a strong correlation between experimental obstructive jaundice and oxidative stress [<xref ref-type="bibr" rid="B64">64</xref>,<xref ref-type="bibr" rid="B65">65</xref>,<xref ref-type="bibr" rid="B68">68</xref>]. However, BDL mainly impairs the liver ability of antioxidant regeneration, especially at the mitochondrial level [<xref ref-type="bibr" rid="B66">66</xref>]. Thus, it has been demonstrated that treatment with antioxidants improves the hepatic cellular redox status [<xref ref-type="bibr" rid="B68">68</xref>,<xref ref-type="bibr" rid="B69">69</xref>]. Indeed, antioxidants have a protective effect on hepatocellular integrity and liver functions by inhibiting reactive oxygen species formation [<xref ref-type="bibr" rid="B66">66</xref>,<xref ref-type="bibr" rid="B67">67</xref>,<xref ref-type="bibr" rid="B69">69</xref>].</p><p>In summary, in this early stage of BDL the insufficient supply of oxygen suffered by the liver, related to hemodynamic alterations, as well the incorrect use of oxygen derived from bile salt hepatotoxicity, would constitute the essential factors that would induce the reduction of hepatic energy metabolism. Consequently, the liver reduces its functional capacity to meet tissue metabolic needs.</p><p>Oxidative liver damage could decrease the intracellular content of proteins participating in energy production and membrane function, (that is, proteins regulating water and ion transport) [<xref ref-type="bibr" rid="B66">66</xref>] inducing cellular and interstitial edema. Also, increased hepatic lipid peroxidation, a high oxidative stress marker [<xref ref-type="bibr" rid="B66">66</xref>], can occur with increased membrane permeability, increased degradation of components of the ECM and edema [<xref ref-type="bibr" rid="B70">70</xref>]. The accumulation of fragments of GAG has been proposed as an important mechanism for edema formation because of the hydrophilic properties of GAGs, and particularly of hyaluronan [<xref ref-type="bibr" rid="B49">49</xref>,<xref ref-type="bibr" rid="B70">70</xref>]. GAGs attract and entrap water and ions, thereby forming hydrated gels, while permitting the flow of cellular nutrients [<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B49">49</xref>,<xref ref-type="bibr" rid="B71">71</xref>]. Under inflammatory conditions hyaluronan is more polydisperse with a preponderance of lower-molecular forms, and favors edematous infiltration of the tissues [<xref ref-type="bibr" rid="B49">49</xref>] as well as the interstitial fluid flow and the tissue lymph pressure gradient [<xref ref-type="bibr" rid="B72">72</xref>]. Additionally, mechanical strain by bile tree dilatation related to BDL can lead from mechanotransduction to modifications in proteoglycans and GAGs remodeling the interstitium [<xref ref-type="bibr" rid="B73">73</xref>,<xref ref-type="bibr" rid="B74">74</xref>]. Matrix stiffness and the mechanical tension that results from cellular adhesion to stiff substrates are instrumental in determining the phenotype of many cells in culture [<xref ref-type="bibr" rid="B75">75</xref>].</p><p>Early mechanical stiffness has been described in the rat CCl<sub>4 </sub>model of fibrosis. This increase in liver stiffness appears to result from matrix crosslinking, and possibly other unknown variables, in addition to matrix quantity [<xref ref-type="bibr" rid="B76">76</xref>]. Also, early changes in mechanical stiffness of the liver could induce myofibroblast differentiation in early liver diseases [<xref ref-type="bibr" rid="B76">76</xref>,<xref ref-type="bibr" rid="B77">77</xref>].</p><p>The myofibroblast function endows activated hepatic stellate cells with the ability to behave like smooth muscle cells. Accordingly, activated stellate cells respond by contraction to vasoactive substances. Also, the subsequent constriction potentially regulates the diameter of liver vasculature and affects hepatic blood flow and pressure [<xref ref-type="bibr" rid="B78">78</xref>].</p></sec><sec><title>The leukocyte phenotype</title><p>Acquiring an active immune phenotype through the cholestatic liver involves both parenchymal (hepatocytes and cholangiocytes) and non-parenchymal cells (sinusoidal endothelial cells, Kupffer cells and hepatic myofibroblasts); blood cells that migrate to the liver interstitium [<xref ref-type="bibr" rid="B77">77</xref>-<xref ref-type="bibr" rid="B81">81</xref>]. However, the interstitial space seems to orchestrate the inflammatory immune cell activity post BDL in the rat.</p><p>In particular, ECM fragments and their receptors exhibit important effects on inflammatory cells and therefore are considered to be clearly implicated in the evolution of the immune interstitial response [<xref ref-type="bibr" rid="B16">16</xref>,<xref ref-type="bibr" rid="B45">45</xref>,<xref ref-type="bibr" rid="B80">80</xref>]. Matrix metalloproteinase (MMPs) are a family of enzymes that degrade components of the ECM and are expressed in the diseased tissues that are inflamed [<xref ref-type="bibr" rid="B82">82</xref>], and are particularly present in cholestatic liver injury [<xref ref-type="bibr" rid="B83">83</xref>,<xref ref-type="bibr" rid="B84">84</xref>]. The enzymatic destruction of the ECM causes the immediate release of the mediators sequestered in its network [<xref ref-type="bibr" rid="B44">44</xref>,<xref ref-type="bibr" rid="B45">45</xref>]. Furthermore, some fragments of the ECM are molecules that have proinflammatory functions, which can enhance the immune response by activating innate and acquired immune responses [<xref ref-type="bibr" rid="B80">80</xref>]. Fragments of ECM proteins and hyaluronan have the ability to promote inflammation by binding Toll-like receptors (TLR)-4 and TLR-2 [<xref ref-type="bibr" rid="B81">81</xref>], by activating the transcriptional regulatory complex of nuclear factor (NF)&#x003ba;B/I&#x003ba;B&#x003b1; and by production of proinflammatory cytokines (that is, TNF&#x003b1;, interleukin (IL)1&#x003b2;) and chemokines that induce the activation and interstitial recruitment of leukocytes [<xref ref-type="bibr" rid="B80">80</xref>].</p><p>Upon activation, T cells undergo polarization with different cytokine profiles. Type 1 (Th1) produces interferon (IFN)&#x003b3; and IL2 and type 2 (Th2) produces IL4, IL5, IL9, IL10 and IL13. In particular, Th2 cytokines are mostly involved in mediating allergic inflammation and chronic fibroproliferative disorders [<xref ref-type="bibr" rid="B79">79</xref>].</p><p>The liver tissue macrophages, or Kupffer cells, are mainly found in the periportal area of the lobule and, due to their location, could play a key role in ischemia/reperfusion injury [<xref ref-type="bibr" rid="B85">85</xref>]. But Kupffer cells are also involved in liver inflammation mediated by cholestasis through the release of biologically active substances that promote the immunopathogenic process [<xref ref-type="bibr" rid="B86">86</xref>] (Figure <xref ref-type="fig" rid="F6">6</xref>). Kupffer cells are clearly altered in biliary obstruction [<xref ref-type="bibr" rid="B86">86</xref>], with an increased phagocytic ability and a marked proinflammatory response to endotoxin and the lipopolysaccharide binding protein (LBP), which are both increased in extrahepatic cholestasis [<xref ref-type="bibr" rid="B85">85</xref>-<xref ref-type="bibr" rid="B87">87</xref>]. The hypersensibility to endotoxin in cholestasis is the cause of increased proinflammatory cytokine synthesis and increased lipid peroxidation [<xref ref-type="bibr" rid="B88">88</xref>], with a worsening of apoptosis and trigger progressing to necrosis [<xref ref-type="bibr" rid="B89">89</xref>]. However, depletion of Kupffer cells aggravates hepatocellular necrosis and inflammation in cholestasic mice [<xref ref-type="bibr" rid="B90">90</xref>]. The LPS-induced proinflammatory response is downregulated by high-density lipoproteins (HDL) that decrease the hepatic proinflammatory signals, restores eNOS activity and lowers portal pressure [<xref ref-type="bibr" rid="B91">91</xref>].</p><p>Neutrophils are key components of the initial inflammatory response to liver cholestatic injury [<xref ref-type="bibr" rid="B92">92</xref>]. In experimental extrahepatic cholestasis, neutrophil interstitial infiltration occurs in early phases, 3 days after BDL [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B93">93</xref>,<xref ref-type="bibr" rid="B94">94</xref>]. Biliary cells contribute to hepatic inflammation by producing neutrophil chemoattractants [<xref ref-type="bibr" rid="B4">4</xref>]. In long-term BDL, rats continue to show an important cell migration around the portal triad and the central vein, associated with a proinflammatory cytokine liver increase [<xref ref-type="bibr" rid="B95">95</xref>]. However, proinflammatory cytokines mediate a heterogeneous hepatocyte response to cholestatic stimuli, with selective hepatocyte down regulation in the periportal zone [<xref ref-type="bibr" rid="B96">96</xref>] (Figure <xref ref-type="fig" rid="F6">6</xref>).</p><p>Both cells, HSCs and myofibroblasts, present in the liver interstitium have the ability to express an immune phenotype. In particular, HSCs secrete a broad spectrum of inflammatory mediators, (that is, chemokines, MCP-1 and RANTES). PAF (platelet activation factor), IL8 and leukocyte adhesion molecules (ICAM-1, VCAM) are required for the recruitment and activation of leukocytes in the interstitium [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B97">97</xref>,<xref ref-type="bibr" rid="B98">98</xref>]. The homing of these cells to the liver interstitial space is favored by HSCs since these cells express MMPs, which enhance the degradation of the extracellular matrix [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B97">97</xref>,<xref ref-type="bibr" rid="B98">98</xref>]. Therefore, HSCs change the initial contractile phenotype to the immune phenotype. It is considered that these phenotypes are intricately related and even interdependent [<xref ref-type="bibr" rid="B97">97</xref>] (Figure <xref ref-type="fig" rid="F6">6</xref>).</p><p>Bacterial translocation is a complication of portal hypertension that is capable of inducing proinflammatory cytokines [<xref ref-type="bibr" rid="B99">99</xref>], and therefore is produced in BDL rats [<xref ref-type="bibr" rid="B99">99</xref>,<xref ref-type="bibr" rid="B100">100</xref>]. Furthermore, bacterial translocation provides a mechanism for the pathogenesis of bacterial infections in experimental cholestasis [<xref ref-type="bibr" rid="B100">100</xref>]. Increased production of TNF&#x003b1; may play an important role in the process of bacterial translocation in rats with cirrhosis and ascitis because TNF&#x003b1; blockade is able to downregulate it without increasing the incidence of systemic infections [<xref ref-type="bibr" rid="B101">101</xref>].</p><p>It has been proposed that the immune response, with expression of pro and anti-inflammatory mediators and recruitment of immune cells, may differ over the course of time of obstructive jaundice [<xref ref-type="bibr" rid="B102">102</xref>]. Thus, after the initial proinflammatory immune response, a regulating anti-inflammatory activity is established [<xref ref-type="bibr" rid="B80">80</xref>] in which T cells and mast cells could participate [<xref ref-type="bibr" rid="B103">103</xref>-<xref ref-type="bibr" rid="B106">106</xref>]. Dendritic cell differentiation in a cholestatic hepatic environment may lead to Th2 polarization and secretion of IL4 and IL10, rather than IFN&#x003b3; [<xref ref-type="bibr" rid="B107">107</xref>]. In the presence of extrahepatic biliary obstruction, the activation of p38, c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase (ERK) considered 'stress kinases' [<xref ref-type="bibr" rid="B108">108</xref>] would be produced. p38 MAP kinase in particular has been suggested to regulate IL10 synthesis through activation of Sp1 transcription factor rather than through the NF&#x003ba;B pathway [<xref ref-type="bibr" rid="B109">109</xref>]. Since IL10 expression is significantly upregulated 14 days after BDL mice [<xref ref-type="bibr" rid="B102">102</xref>], anti-inflammatory mediators may modulate the production of proinflammatory cytokines in long-term cholestasis, thus resulting in susceptibility to bacterial translocation and infection [<xref ref-type="bibr" rid="B102">102</xref>]. In this way, ECM molecules, like hyaluronan networks, might serve as scaffolds to prevent the loss of ECM components during inflammation and to sequester proinflammatory mediators. That is why a protective or 'counter-inflammatory' role has been suggested for the highly crosslinked hyaluronan [<xref ref-type="bibr" rid="B46">46</xref>,<xref ref-type="bibr" rid="B47">47</xref>].</p><p>Jaundice is also an important mediator of the liver inflammatory response in this experimental model of cholestasis. Bilirubin is produced via reduction of heme-derived biliverdin by biliverdin reductase [<xref ref-type="bibr" rid="B110">110</xref>]. Bilirubin has a number of new and interesting biochemical and biological properties [<xref ref-type="bibr" rid="B111">111</xref>]. In addition to having a protective role against oxidative stress [<xref ref-type="bibr" rid="B111">111</xref>], bilirubin has antiapoptotic and antimutagenic properties [<xref ref-type="bibr" rid="B112">112</xref>] as well as a strong role as an immune modulator [<xref ref-type="bibr" rid="B113">113</xref>,<xref ref-type="bibr" rid="B114">114</xref>]. Thus, in a mouse model of endotoxemia, a single dose of bilirubin in addition to its antioxidant effects also exerts a strong anti-inflammatory activity [<xref ref-type="bibr" rid="B114">114</xref>].</p><p>Cholestatic jaundice also occurs in the setting of sepsis [<xref ref-type="bibr" rid="B114">114</xref>]. Liver abnormalities in sepsis include cholestasis and hyperbilirubinemia. Hyperbilirubinemia particularly develops in sepsis in the setting of bacteriemia and precedes positive blood cultures in a third of all cases [<xref ref-type="bibr" rid="B115">115</xref>].</p></sec><sec><title>The angiogenic phenotype</title><p>The late evolutive phase in the development of surgical experimental liver cholestasis or endocrine phase is characterized by the predominance of angiogenesis. Angiogenesis is defined as the growth of new vessels from preexisting ones [<xref ref-type="bibr" rid="B116">116</xref>].</p><p>Although the final objective of endothelial growth is to form new vessels for oxygen, substrates and blood cells (vascular phase), other functions could also be carried out, like antioxidative and anti-immune properties, before the new vessels are formed (prevascular phase) [<xref ref-type="bibr" rid="B117">117</xref>,<xref ref-type="bibr" rid="B118">118</xref>].</p><p>Angiogenesis requires migration of endothelial cells into the interstitial space with the subsequent proliferation and differentiation into capillaries [<xref ref-type="bibr" rid="B118">118</xref>]. In BDL rats the proliferation of bile ductules, like in liver organogenesis, precedes the proliferation of the escorting microvessels. After 1 week of BDL, despite the noticeable proliferation of bile ducts, the peribiliary arterial plexus maintains its normal architecture. By contrast, after 2 and 4 weeks of BDL significant microvasculature proliferation is developed, extending from the peribiliary plexus of bile tracts [<xref ref-type="bibr" rid="B59">59</xref>] (Figure <xref ref-type="fig" rid="F7">7</xref>).</p><fig position="float" id="F7"><label>Figure 7</label><caption><p><bold>Angiogenic phenotype during the evolution of obstructive cholestasis.</bold> Increase in the proliferation of cholangiocytes with an important development of the peribiliar plexus and sinusoidal arterializations with hepatocytary  aplasia. AC: arterial capillar; C: cholangiocyte; ECM: extracellular matrix;H: hepatocyte; M: myofibroblast; PP: peribiliary arterial plexus; SS: sinusoidal space;  ; Th<sub>2</sub>: T cell h<sub>2</sub>; Treg: regulatory T cell.    </p></caption><graphic xlink:href="1755-1536-1-6-7"/></fig><p>The main role of the cholangiocyte function in angiogenesis post BDL has been corroborated, associating hepatic artery ligation to cholestasis induced by BDL in the rat. The liver suffers increased cholangiocyte apoptosis, impaired cholangiocyte proliferation, decreased cholangiocyte vascular endothelial growth factor (VEGF) secretion and the disappearance of the peribiliary plexus. Interestingly enough, cholangiocyte functions and, thus, the integrity of the peribiliary plexus are prevented by treatment with recombinant VEGF-A [<xref ref-type="bibr" rid="B119">119</xref>]. Likewise, in human liver transplantation biliary regeneration occurs as an initial proliferation of the epithelial compartment, followed by the vascular compartment, which seems to be supported by induced VEGF-A expression by the epithelial compartment [<xref ref-type="bibr" rid="B120">120</xref>].</p><p>The ECM plays critical roles in most blood vessel formation processes. In the angiogenic process, ECM components and their fragments provide direction for regulating vessel cell migration, proliferation, differentiation and survival [<xref ref-type="bibr" rid="B42">42</xref>]. Integrins are the major type of ECM receptor in endothelial cells [<xref ref-type="bibr" rid="B121">121</xref>].</p><p>Mast cell hyperplasia is associated with the proliferation of bile ductules during extrahepatic cholestasis [<xref ref-type="bibr" rid="B105">105</xref>,<xref ref-type="bibr" rid="B106">106</xref>]. These findings suggest that mast cells accumulating in the portal triads may be involved in bile duct proliferation. At the same time, the recanalization of the ligated common bile duct led to an abrupt and transient increase in the number of mast cells associated with a rapid increase in the number of apoptotic biliary epithelial cells. These findings suggested that liver interstitial mast cells may relate to the hepatic remodeling through the induction of apoptosis [<xref ref-type="bibr" rid="B105">105</xref>].</p><p>In long-term extrahepatic cholestasis, the predominating hepatic alteration is marked ductular proliferation with a mild portal inflammatory infiltration and apoptosis [<xref ref-type="bibr" rid="B122">122</xref>]. However, extrahepatic cholestasis also makes it possible to create a model of biliary fibrosis in the long term [<xref ref-type="bibr" rid="B122">122</xref>,<xref ref-type="bibr" rid="B123">123</xref>] (Figure <xref ref-type="fig" rid="F8">8</xref>). Hepatic fibrosis post BDL in rodents is the consequence of an inflammatory process of biliary origin [<xref ref-type="bibr" rid="B124">124</xref>,<xref ref-type="bibr" rid="B125">125</xref>]. Liver fibrosis is the excessive accumulation of ECM proteins including collagen [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B97">97</xref>,<xref ref-type="bibr" rid="B98">98</xref>]. A fundamental concept regarding the pathogenesis of hepatic fibrosis is that the process represents the body's wound-healing response to injury and is similar to the response of other organs to recurrent injury [<xref ref-type="bibr" rid="B97">97</xref>]. HSC activation is a key pathogenic feature that underlies liver fibrosis because the resulting myofibroblasts are mainly responsible for connective tissue reassembly [<xref ref-type="bibr" rid="B97">97</xref>,<xref ref-type="bibr" rid="B98">98</xref>,<xref ref-type="bibr" rid="B126">126</xref>]. Multiple and varied stimuli contribute to the induction and maintenance of activation, including oxidative stress, neurotransmitters (norepinephrine), the renin-angiotensin cascade, cytokines (IL4, IL13), chemokines and growth factors, that is, transforming growth factor (TGF)-&#x003b2;1 and connective tissue growth factor (CTGF) [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B77">77</xref>,<xref ref-type="bibr" rid="B97">97</xref>,<xref ref-type="bibr" rid="B98">98</xref>,<xref ref-type="bibr" rid="B122">122</xref>,<xref ref-type="bibr" rid="B126">126</xref>,<xref ref-type="bibr" rid="B127">127</xref>]. HSCs are further stimulated in a paracrine mode by invaded thrombocytes, polymorphonuclear leucocytes, mast cells and lymphocytes but also by activated Kupffer cells, sinusoidal endothelial cells and hepatocytes to transdifferentiate to myofibroblasts [<xref ref-type="bibr" rid="B81">81</xref>,<xref ref-type="bibr" rid="B98">98</xref>,<xref ref-type="bibr" rid="B122">122</xref>]. HSCs in the liver could also originate from the bone marrow and acquire the myofibroblast phenotype if the adequate, injurious microenvironment of the liver is present [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B98">98</xref>] (Figure <xref ref-type="fig" rid="F7">7</xref>).</p><fig position="float" id="F8"><label>Figure 8</label><caption><p><bold>Periportal biliary proliferation that invades Rappaport spaces I and II</bold>. Peribiliary fibrosis is observed (hematoxylin and eosin (H&#x00026;E) stain, 50 &#x000d7; magnification).</p></caption><graphic xlink:href="1755-1536-1-6-8"/></fig><p>Hepatic myofibroblasts are the principal cell type responsible for promoting the deposition of crosslinked fibrillar collagen in the cholestatic liver [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B98">98</xref>]. The coexistence of epithelial-mesenchymal transition from biliary epithelial or hepatocyte cells has also been proposed [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B128">128</xref>,<xref ref-type="bibr" rid="B129">129</xref>].</p><p>During the establishment of liver fibrosis, the persistence of injurious agents and the inflammatory response are followed by 'sinusoidal capillarization', which mainly consists of the transformation of fenestrated hepatic sinusoids into continuous capillaries, accompanied by the deposition of a continuous basement membrane near the endothelial cells and hepatocytes [<xref ref-type="bibr" rid="B106">106</xref>]. Mast cells in fibrotic livers can also be involved in hepatic arterialization [<xref ref-type="bibr" rid="B106">106</xref>,<xref ref-type="bibr" rid="B130">130</xref>]. Capillarization hinders the normal exchanges between plasma and hepatocytes and is the main cause of worsening liver function [<xref ref-type="bibr" rid="B130">130</xref>]. In turn, hepatic macrophages can regulate the influx of neutrophils, which may play a direct role in matrix degradation [<xref ref-type="bibr" rid="B131">131</xref>]. Also, infiltrating neutrophils seem to accumulate preferentially near the proliferating bile ductules and therefore they could influence the remodeling biliary epithelial cells [<xref ref-type="bibr" rid="B131">131</xref>].</p><p>Oxidative and enzymatic stress would, respectively, be produced during ischemia/reperfusion. Furthermore, leukocyte phenotypes in experimental obstructive cholestasis could be involved in the pathogenesis of bile duct epithelial cell proliferation and in the looping and reduplication of the duct and ductules [<xref ref-type="bibr" rid="B132">132</xref>]. Thus, it has been suggested that the hepatoprotective effect of honey in BDL rats could be attributed to both to their antioxidant and anti-inflammatory activities [<xref ref-type="bibr" rid="B132">132</xref>].</p><p>Intense biliary proliferation in the portal spaces characterizes long-term extrahepatic microsurgical cholestasis in the rat. The proliferating bile ducts invade zones 1 and 2 or Rappaport acinus, but not zone 3 or the pericentral zone [<xref ref-type="bibr" rid="B28">28</xref>]. This is why it could be considered an 'atypical' proliferation [<xref ref-type="bibr" rid="B11">11</xref>]. In essence, the pathophysiologic response of the liver, when bile flow (extrahepatic cholestasis) and/or portal venous (sinusoidal capillarization with portal hypertension) are impaired, is atrophy of the involved hepatic area and hypertrophy of the uninvolved area [<xref ref-type="bibr" rid="B133">133</xref>]. Histopathologically the atrophy-hypertrophy complex is characterized by septal fibrosis in the atrophic liver with biliary piecemeal necrosis, apoptosis and ductular proliferation [<xref ref-type="bibr" rid="B132">132</xref>,<xref ref-type="bibr" rid="B133">133</xref>] (Figure <xref ref-type="fig" rid="F7">7</xref>).</p><p>Cholangiocytes are considered biologically important epithelia because of the diverse array of cellular processes in which they participate, including transport of water, ions and solutes [<xref ref-type="bibr" rid="B134">134</xref>]. The cholangiocytes have been proposed to be the principle target cell for bile acids in the liver. Bile acids significantly alter cholangiocyte secretion, proliferation and survival [<xref ref-type="bibr" rid="B135">135</xref>]. Thus, bile acids can counteract the loss of bile ducts induced by cholinergic denervation in the BDL rat [<xref ref-type="bibr" rid="B136">136</xref>]. However, during their intense proliferation in obstructive cholestasis, proliferating cholangiocytes acquire the phenotype of neuroendocrine cells and secrete different substances including neurotransmitters (serotonin) [<xref ref-type="bibr" rid="B137">137</xref>], neuropeptides (opioid peptides such as met-enkephalin) [<xref ref-type="bibr" rid="B138">138</xref>-<xref ref-type="bibr" rid="B141">141</xref>], hormones (prolactin) [<xref ref-type="bibr" rid="B142">142</xref>] and their receptors (estrogens) [<xref ref-type="bibr" rid="B11">11</xref>] and growth factors, (that is, insulin-like growth factor (IGF), platelet-derived growth factor (PDGF), hepatocyte growth factor (HGF), TGF&#x003b2; and VEGF) [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B136">136</xref>]. A great deal of evidence indicates that hepatic progenitor cell activation in the cholestatic liver is regulated by neural and neuroendocrine factors in modulating non-malignant and malignant cholangiocyte biology [<xref ref-type="bibr" rid="B136">136</xref>].</p><p>Microsurgical extrahepatic cholestasis decreases the liver cytochrome <italic>c </italic>oxidase activity [<xref ref-type="bibr" rid="B143">143</xref>]. Cytochrome oxidation accounts for more than 90% of oxygen consumption by living organisms on earth, and is essential for vital organs such as the liver [<xref ref-type="bibr" rid="B144">144</xref>]. Therefore, changes in the phenotype of bile ductule cells in association with a decrease in cytochrome <italic>c </italic>oxidase activity in the cholestatic liver may be attributable to the lower energy requirements of the neuroendocrine phenotype expressed by these cells [<xref ref-type="bibr" rid="B143">143</xref>] (Figure <xref ref-type="fig" rid="F9">9</xref>).</p><fig position="float" id="F9"><label>Figure 9</label><caption><p>Significant inhibition of liver cytochrome oxidase activity after microsurgical extrahepatic cholestasis in the rat.</p></caption><graphic xlink:href="1755-1536-1-6-9"/></fig><p>Bile duct ligation in mice has been widely used to define specific phases of acute and chronic injury and repair in the different cellular compartments of the liver [<xref ref-type="bibr" rid="B145">145</xref>]. Bile duct ligation elicits dynamic changes in mouse liver. Acute liver injury, with necrotic and apoptotic cell death and biliary infarcts, is followed by continuous tissue repair, lymphocyte and Kupffer cell infiltration and accumulation of collagen during the second week of postoperative evolution. In this way, Kupffer cells abrogate liver injury in mice by cytokine-dependent mechanisms that include the production of IL6 [<xref ref-type="bibr" rid="B146">146</xref>]. It has been demonstrated that endogenous hepatocyte growth factor (HGF) is a reasonable strategy to attenuate hepatic inflammation, necrosis and apoptosis and it has regenerative potential against cholestatic hepatitis [<xref ref-type="bibr" rid="B147">147</xref>]. Growth hormone (GH) administration also upregulates hepatocyte proliferation and attenuates fibrogenic response at day 28 of bile duct ligation in mice. Therefore, this endocrine pathway is a potential mechanism to modulate the liver repair response to bile duct ligation [<xref ref-type="bibr" rid="B148">148</xref>]. In mice biliary obstruction, as a model of liver repair response to biliary injury, many targeted genes with metabolic-, profibrotic- and proliferation-specific functions are likely involved in the acute phase of injury (first week) and in the chronic phase (4 weeks) [<xref ref-type="bibr" rid="B149">149</xref>]. However, although cholangiocellular proliferation occurs early in large bile ducts on days 2&#x02013;3 and in small bile ducts on day 5, it only produces the rupture of normal liver architecture in the chronic evolutive stages [<xref ref-type="bibr" rid="B145">145</xref>]. In summary, these time-related changes in extrahepatic cholestatic mouse are similar to those previously described in rat. Since mice are frequently used in knockout studies, this experimental model could be very useful to study novel mechanistic/molecular biology insights into the pathobiology of obstructive cholestasis in rodent models.</p><p>Depression of cholangiocyte mitochondrial respiration in obstructive cholestasis could induce hypoxia-inducible factor (HIF)1&#x003b1; activation and overexpression, by a similar mechanism to one that has been described in tumor cells [<xref ref-type="bibr" rid="B150">150</xref>,<xref ref-type="bibr" rid="B151">151</xref>]. This supposed overactivation of HIF1&#x003b1;, secondary to the decrease in oxygen metabolism with reduced ATP generation, induces the obtaining of energy via other mechanisms. For example, cholangiocytes could generate sufficient reduced nicotinamide dinucleotide phosphate (NADPH) for their biological functions through the continuous replenishment of Krebs cycle intermediates [<xref ref-type="bibr" rid="B152">152</xref>]. By these anaplerotic mechanisms, cholangiocytes could obtain sufficient energy not only for the new functions acquired but also for proliferation [<xref ref-type="bibr" rid="B152">152</xref>,<xref ref-type="bibr" rid="B153">153</xref>].</p></sec><sec><title>Conclusion</title><p>Given the plasticity of HSCs and hepatic parenchymal cells (hepatocyte-cholangiocyte axis) it should be kept in mind that while the cholestatic liver develops, they can express the same phenotypes as the post-traumatic inflammatory response [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>] such as: an ischemic/reperfusion phenotype (hypoxic) a leukocytic phenotype (with pro- and anti-immune response) and finally an angiogenic phenotype with cholangiocyte proliferation and fibrosis.</p><p>During these evolutive phases, it could be considered that the cholagiocyte adopts a progressive metabolic complexity (neuroendocrine), which is associated with a growing structural complexity. Cholangiocytes proliferation is a key mechanism capable of conditioning the evolution of liver damage. In fact, proliferating cholangiocytes acquire the phenotype of neuroendocrine cells and secrete different substances that represent the tools of crosstalk with other hepatic cells [<xref ref-type="bibr" rid="B11">11</xref>]. In this way, the activation of this neuroendocrine compartment can result in the persistence of the inflammatory response, which would increase the chance for malignant cell transformation. Thus, this 'atypical' biliar proliferation seems to be able to induce an inflammatory response in the remaining liver and includes a concept of premalignancy [<xref ref-type="bibr" rid="B11">11</xref>].</p><p>In essence, the cholestatic liver changes include fibroblastic cells and extracellular matrix production, inflammation with an immune response, represented by lymphocytes, macrophages and dendritic cells and finally, angiogenesis, shown by newly formed blood vessels [<xref ref-type="bibr" rid="B154">154</xref>]. Essentially, all of the elements that constitute the inflammatory response participate in this 'host liver reaction', which may have a trophic purpose for the development of the stiffened biliary cholestatic liver. The persistence of this inflammatory response through a longer evolution would induce an 'atypical' ductular proliferation with the development of a neuroendocrine compartment [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B36">36</xref>-<xref ref-type="bibr" rid="B38">38</xref>] and, finally, a malignant cell transformation as it occurs in humans by producing biliary tract cancer (cholangiocarcinoma) [<xref ref-type="bibr" rid="B136">136</xref>].</p></sec><sec><title>List of abbreviations</title><p>BDL: bile duct ligation; ECM: extracellular matrix; ERK: extracellular signal-regulated kinase; GAG: glycosaminoglycans; HGF: hepatocyte growth factor; HSC: hepatic stellate cell; HDL: high-density lipoprotein; HIF: hypoxia-inducible factor; IGF: insulin-like growth factor; IL: interleukin; iNOS: inducible nitric oxide synthase; IFN&#x003b3;: interferon gamma; JNK: c-Jun N-terminal kinase; LBP: lipopolysaccharide binding protein; LPS: lipopolysaccharide; MMP: matrix metalloproteinase; NADPH; reduced nicotinamide dinucleotide phosphate; NO: nitric oxide; PAF: platelet activation factor; PDGF: platelet-derived growth factor; ROS: reactive oxygen species; RNS: reactive nitrogen species; TLR: Toll-like receptors; TGF: transforming growth factor; TNF&#x003b1;: tumor necrosis factor &#x003b1;; VEGF: vascular endothelial growth factor.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>MAA, JA and JLA conceived the integration of inflammation in experimental cholestasis. JIA, MD and JGD supported important clinical aspects and discussed the manuscript. MAA, JLA and JA wrote the final version of the manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>We would like to acknowledge the librarians of the School of Medicine Library (UCM), especially the Director, Juan Carlos Dom&#x000ed;nguez, Maria-Jos&#x000e9; Valdemoro, Maria Elena Vicente for her assistance in preparing the manuscript and Elizabeth Mascola for translating the text into English. This study was supported in part by a Grant from MEC.SEJ 2004/07445 and the Department of Health. Castilla-La Mancha Regional Council (Ref. 04047-00).</p></sec></ack><ref-list><ref id="B1"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Schaffner</surname><given-names>F</given-names></name><name><surname>Popper</surname><given-names>H</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Wright R, Alberti KGMM, Karran S, Millward-Sadler GH</surname></name></person-group><article-title>Classification and mechanism of cholestasis</article-title><source>Liver and biliary disease Pathophysiology Diagnosis Management</source><year>1979</year><publisher-name>London. Oxford: WB Saunders Company Ltd</publisher-name><fpage>296</fpage><lpage>323</lpage></citation></ref><ref id="B2"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Sherlock</surname><given-names>S</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Sherlock S</surname></name></person-group><article-title>Cholestasis</article-title><source>Diseases of the liver and biliary System</source><year>1989</year><edition>8</edition><publisher-name>London: Blackwell Scientific Publications</publisher-name><fpage>248</fpage><lpage>272</lpage></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>MK</given-names></name><name><surname>Crawford</surname><given-names>JM</given-names></name></person-group><article-title>The pathology of cholestasis</article-title><source>Semin Liver Dis</source><year>2004</year><volume>24</volume><fpage>21</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">15085484</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>JM</given-names></name><name><surname>Maher</surname><given-names>JJ</given-names></name></person-group><article-title>Bile duct ligation in rats induces biliary expression of cytokine-induced neutrophil chemoattractant</article-title><source>Gastroenterology</source><year>2000</year><volume>118</volume><fpage>1157</fpage><lpage>1168</lpage><pub-id pub-id-type="pmid">10833491</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gujral</surname><given-names>JS</given-names></name><name><surname>Farhood</surname><given-names>A</given-names></name><name><surname>Bajt</surname><given-names>ML</given-names></name><name><surname>Jaeschke</surname><given-names>H</given-names></name></person-group><article-title>Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice</article-title><source>Hepatology</source><year>2003</year><volume>38</volume><fpage>355</fpage><lpage>363</lpage><pub-id pub-id-type="pmid">12883479</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bataller</surname><given-names>R</given-names></name><name><surname>Brenner</surname><given-names>DA</given-names></name></person-group><article-title>Liver fibrosis</article-title><source>J Clin Invest</source><year>2005</year><volume>115</volume><fpage>209</fpage><lpage>218</lpage><pub-id pub-id-type="pmid">15690074</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aller</surname><given-names>MA</given-names></name><name><surname>Arias</surname><given-names>JL</given-names></name><name><surname>Nava</surname><given-names>MP</given-names></name><name><surname>Arias</surname><given-names>J</given-names></name></person-group><article-title>Posttraumatic inflammation is a complex response based on the pathological expression of the nervous, immune, and endocrine functional systems</article-title><source>Exp Biol Med (Maywood)</source><year>2004</year><volume>229</volume><fpage>170</fpage><lpage>181</lpage><pub-id pub-id-type="pmid">14734796</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aller</surname><given-names>MA</given-names></name><name><surname>Arias</surname><given-names>JL</given-names></name><name><surname>Sanchez-Patan</surname><given-names>E</given-names></name><name><surname>Arias</surname><given-names>J</given-names></name></person-group><article-title>The inflammatory response: an efficient way of life</article-title><source>Med Sci Monit</source><year>2006</year><volume>12</volume><fpage>RA225</fpage><lpage>234</lpage><pub-id pub-id-type="pmid">17006415</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakanuma</surname><given-names>Y</given-names></name><name><surname>Hoso</surname><given-names>M</given-names></name><name><surname>Sanzen</surname><given-names>T</given-names></name><name><surname>Sasaki</surname><given-names>M</given-names></name></person-group><article-title>Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply</article-title><source>Microsc Res Tech</source><year>1997</year><volume>38</volume><fpage>552</fpage><lpage>570</lpage><pub-id pub-id-type="pmid">9330346</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Theise</surname><given-names>ND</given-names></name><name><surname>Saxena</surname><given-names>R</given-names></name><name><surname>Portman</surname><given-names>BC</given-names></name><name><surname>Thung</surname><given-names>SN</given-names></name><name><surname>Yee</surname><given-names>H</given-names></name><name><surname>Chiriboga</surname><given-names>L</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Crawford</surname><given-names>JM</given-names></name></person-group><article-title>The cannals of Hering and hepatic stem cells in humans</article-title><source>Hepatology</source><year>1999</year><volume>30</volume><fpage>1425</fpage><lpage>1433</lpage><pub-id pub-id-type="pmid">10573521</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alvaro</surname><given-names>D</given-names></name><name><surname>Mancino</surname><given-names>MG</given-names></name><name><surname>Glaser</surname><given-names>S</given-names></name><name><surname>Gaudio</surname><given-names>E</given-names></name><name><surname>Marzioni</surname><given-names>M</given-names></name><name><surname>Francis</surname><given-names>H</given-names></name><name><surname>Alpini</surname><given-names>G</given-names></name></person-group><article-title>Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver</article-title><source>Gastroenterology</source><year>2007</year><volume>132</volume><fpage>415</fpage><lpage>431</lpage><pub-id pub-id-type="pmid">17241889</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poli</surname><given-names>G</given-names></name></person-group><article-title>Pathogenesis of liver fibrosis: role of oxidative stress</article-title><source>Mol Aspects Med</source><year>2000</year><volume>21</volume><fpage>49</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">10978499</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>SL</given-names></name></person-group><article-title>Protean, multifunctional and enigmatic cells of the liver</article-title><source>Physiol Rev</source><year>2008</year><volume>88</volume><fpage>125</fpage><lpage>172</lpage><pub-id pub-id-type="pmid">18195085</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iredale</surname><given-names>JP</given-names></name></person-group><article-title>Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ</article-title><source>J Clin Invest</source><year>2007</year><volume>117</volume><fpage>539</fpage><lpage>548</lpage><pub-id pub-id-type="pmid">17332881</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Henderson</surname><given-names>NC</given-names></name><name><surname>Iredale</surname><given-names>JP</given-names></name></person-group><article-title>Liver fibrosis: cellular mechanisms of progression and resolution</article-title><source>Clin Sci</source><year>2007</year><volume>112</volume><fpage>265</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">17261089</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adair-Kirk</surname><given-names>TL</given-names></name><name><surname>Senior</surname><given-names>RM</given-names></name></person-group><article-title>Fragments of extracellular matrix as mediators of inflammation</article-title><source>Int J Biochem Cell Biol</source><year>2008</year><volume>40</volume><fpage>1101</fpage><lpage>1110</lpage><pub-id pub-id-type="pmid">18243041</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O'Connor</surname><given-names>M</given-names></name></person-group><article-title>Mechanical biliary obstruction. A review of the multisystemic consequences of obstructive jaundice and their impact on perioperative morbility and mortality</article-title><source>Am Surgeon</source><year>1985</year><volume>51</volume><fpage>245</fpage><lpage>251</lpage><pub-id pub-id-type="pmid">3888015</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kounturas</surname><given-names>J</given-names></name><name><surname>Billing</surname><given-names>BH</given-names></name><name><surname>Scheuer</surname><given-names>PJ</given-names></name></person-group><article-title>Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat</article-title><source>Br J Exp Pathol</source><year>1984</year><volume>65</volume><fpage>305</fpage><lpage>311</lpage><pub-id pub-id-type="pmid">6743531</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holmberg</surname><given-names>JT</given-names></name><name><surname>Hederstrom</surname><given-names>E</given-names></name><name><surname>Ihse</surname><given-names>I</given-names></name></person-group><article-title>A method to prevent recanalization of the transected bile duct in the rat</article-title><source>Scand J Gastroenterol</source><year>1985</year><volume>20</volume><fpage>428</fpage><lpage>432</lpage><pub-id pub-id-type="pmid">4023608</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aller</surname><given-names>MA</given-names></name><name><surname>Lorente</surname><given-names>L</given-names></name><name><surname>Arias</surname><given-names>J</given-names></name></person-group><article-title>Hepatic artery ischemia in rats with cholestasis. Different response of the lobes</article-title><source>J Hepatol</source><year>1991</year><volume>13</volume><fpage>S87</fpage><pub-id pub-id-type="pmid">1822520</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aller</surname><given-names>MA</given-names></name><name><surname>Lorente</surname><given-names>L</given-names></name><name><surname>Alonso</surname><given-names>S</given-names></name><name><surname>Rodriguez</surname><given-names>G</given-names></name><name><surname>Arias</surname><given-names>J</given-names></name></person-group><article-title>Different types of response to hepatic arterial ischemia in rats with cholestasis</article-title><source>Surg Res Commun</source><year>1993</year><volume>14</volume><fpage>269</fpage><lpage>280</lpage></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aller</surname><given-names>MA</given-names></name><name><surname>Duran</surname><given-names>M</given-names></name><name><surname>Ortega</surname><given-names>L</given-names></name><name><surname>Arias</surname><given-names>JL</given-names></name><name><surname>Nava</surname><given-names>MP</given-names></name><name><surname>Prieto</surname><given-names>I</given-names></name><name><surname>Arias</surname><given-names>J</given-names></name></person-group><article-title>Comparative study of macro- and microsurgical extrahepatic cholestasis in the rat</article-title><source>Microsurgery</source><year>2004</year><volume>24</volume><fpage>442</fpage><lpage>447</lpage><pub-id pub-id-type="pmid">15389969</pub-id></citation></ref><ref id="B23"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Castaing</surname><given-names>D</given-names></name><name><surname>Houssin</surname><given-names>D</given-names></name><name><surname>Bismuth</surname><given-names>H</given-names></name></person-group><article-title>Anatomy of the liver and portal system of the rat</article-title><source>Hepatic and portal surgery in the rat</source><year>1980</year><publisher-name>Paris: Editorial Masson</publisher-name><fpage>27</fpage><lpage>46</lpage></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aller</surname><given-names>MA</given-names></name><name><surname>Lorente</surname><given-names>L</given-names></name><name><surname>Alonso</surname><given-names>S</given-names></name><name><surname>Arias</surname><given-names>J</given-names></name></person-group><article-title>A model of cholestasis in the rat, using a microsurgical technique</article-title><source>Scand J Gastroenterol</source><year>1993</year><volume>28</volume><fpage>10</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">8430270</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abraldes</surname><given-names>JG</given-names></name><name><surname>Pasarin</surname><given-names>M</given-names></name><name><surname>Garcia-Pagan</surname><given-names>JC</given-names></name></person-group><article-title>Animal models of portal hypertension</article-title><source>World J Gastroenterol</source><year>2006</year><volume>12</volume><fpage>6577</fpage><lpage>6584</lpage><pub-id pub-id-type="pmid">17075968</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>PL</given-names></name><name><surname>Lee</surname><given-names>SS</given-names></name></person-group><article-title>Vitamin K1 improves survival in bile-duct-ligated rats with cirrhosis</article-title><source>J Hepatol</source><year>1995</year><volume>23</volume><fpage>235</fpage><pub-id pub-id-type="pmid">7499802</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>Y-T</given-names></name><name><surname>Hsu</surname><given-names>Y-C</given-names></name><name><surname>Chen</surname><given-names>C-Y</given-names></name><name><surname>Liu</surname><given-names>C-T</given-names></name><name><surname>Wei</surname><given-names>Y-H</given-names></name></person-group><article-title>Oxidative-stress-related changes in the livers of bile-duct-ligated rats</article-title><source>J Biomed Sci</source><year>2003</year><volume>10</volume><fpage>170</fpage><lpage>178</lpage><pub-id pub-id-type="pmid">12595753</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aller</surname><given-names>MA</given-names></name><name><surname>Nava</surname><given-names>MP</given-names></name><name><surname>Arias</surname><given-names>JL</given-names></name><name><surname>Duran</surname><given-names>M</given-names></name><name><surname>Prieto</surname><given-names>I</given-names></name><name><surname>Llamas</surname><given-names>MA</given-names></name><name><surname>Arias</surname><given-names>J</given-names></name></person-group><article-title>Microsurgical extrahepatic cholestasis in the rat: a long-term study</article-title><source>J Invest Surg</source><year>2004</year><volume>17</volume><fpage>99</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">15204716</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>C-C</given-names></name><name><surname>Wang</surname><given-names>S-S</given-names></name><name><surname>Lee</surname><given-names>FY</given-names></name><name><surname>Chang</surname><given-names>FY</given-names></name><name><surname>Lin</surname><given-names>HC</given-names></name><name><surname>Hou</surname><given-names>MC</given-names></name><name><surname>Huang</surname><given-names>MC</given-names></name><name><surname>Lee</surname><given-names>SD</given-names></name></person-group><article-title>Effects of endothelin-1 on portal-systemic collaterals of common bile duct-ligated cirrhotic rats</article-title><source>Eur J Clin Invest</source><year>2004</year><volume>34</volume><fpage>290</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">15086361</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Katsuta</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>X-J</given-names></name><name><surname>Ohsuga</surname><given-names>M</given-names></name><name><surname>Akimoto</surname><given-names>T</given-names></name><name><surname>Komeichi</surname><given-names>H</given-names></name><name><surname>Shimizu</surname><given-names>S</given-names></name><name><surname>Inami</surname><given-names>T</given-names></name><name><surname>Miyamoto</surname><given-names>A</given-names></name><name><surname>Satomura</surname><given-names>K</given-names></name><name><surname>Takano</surname><given-names>T</given-names></name></person-group><article-title>Hemodynamic features of advanced cirrhosis due to chronic bile duct ligation</article-title><source>J Nippon Med Sch</source><year>2005</year><volume>72</volume><fpage>217</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">16113492</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Moreno</surname><given-names>LM</given-names></name><name><surname>Aller</surname><given-names>MA</given-names></name><name><surname>Conejo</surname><given-names>NM</given-names></name><name><surname>Gomez</surname><given-names>MA</given-names></name><name><surname>Martin</surname><given-names>FR</given-names></name><name><surname>Arias</surname><given-names>J</given-names></name><name><surname>Arias</surname><given-names>JL</given-names></name></person-group><article-title>Brain Ag-NOR activity in cholestatic rats with hepatic encephalopathy</article-title><source>Hepatol Res</source><year>2002</year><volume>24</volume><fpage>275</fpage><lpage>281</lpage><pub-id pub-id-type="pmid">12393029</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Moreno</surname><given-names>LM</given-names></name><name><surname>Conejo</surname><given-names>NM</given-names></name><name><surname>Gonzalez-Pardo</surname><given-names>H</given-names></name><name><surname>Aller</surname><given-names>MA</given-names></name><name><surname>Nava</surname><given-names>MP</given-names></name><name><surname>Arias</surname><given-names>J</given-names></name><name><surname>Arias</surname><given-names>JL</given-names></name></person-group><article-title>Evaluation of two experimental models of hepatic encephalopathy in rats</article-title><source>Braz J Med Biol Res</source><year>2005</year><volume>38</volume><fpage>127</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">15665999</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lorente</surname><given-names>L</given-names></name><name><surname>Aller</surname><given-names>MA</given-names></name><name><surname>Arias</surname><given-names>JL</given-names></name><name><surname>Arias</surname><given-names>J</given-names></name></person-group><article-title>Nitric oxide (NO) is a highly reactive free radical with a multitude of organ specific regulatory functions</article-title><source>Ann Surg</source><year>1996</year><volume>224</volume><fpage>688</fpage><lpage>689</lpage><pub-id pub-id-type="pmid">8916885</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aller</surname><given-names>MA</given-names></name><name><surname>Arias</surname><given-names>JL</given-names></name><name><surname>Arias</surname><given-names>J</given-names></name></person-group><article-title>Post-traumatic inflammatory response: perhaps a succession of phases with a nutritional purpose</article-title><source>Med Hypotheses</source><year>2004</year><volume>63</volume><fpage>42</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">15193345</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Freitas</surname><given-names>I</given-names></name><name><surname>Baronzio</surname><given-names>GF</given-names></name><name><surname>Bono</surname><given-names>B</given-names></name><name><surname>Griffini</surname><given-names>P</given-names></name><name><surname>Bertone</surname><given-names>V</given-names></name><name><surname>Sonzini</surname><given-names>N</given-names></name><name><surname>Magrassi</surname><given-names>GR</given-names></name><name><surname>Bonandrini</surname><given-names>L</given-names></name><name><surname>Gerzeli</surname><given-names>G</given-names></name></person-group><article-title>Tumor interstitial fluid: misconsidered component of the internal milieu of a solid tumor</article-title><source>Anticancer Res</source><year>1997</year><volume>17</volume><fpage>165</fpage><lpage>172</lpage><pub-id pub-id-type="pmid">9066647</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arias</surname><given-names>JI</given-names></name><name><surname>Aller</surname><given-names>MA</given-names></name><name><surname>Arias</surname><given-names>J</given-names></name></person-group><article-title>The use of inflammation by tumor cells</article-title><source>Cancer</source><year>2005</year><volume>104</volume><fpage>223</fpage><lpage>228</lpage><pub-id pub-id-type="pmid">15937911</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arias</surname><given-names>JI</given-names></name><name><surname>Aller</surname><given-names>MA</given-names></name><name><surname>Sanchez-Patan</surname><given-names>F</given-names></name><name><surname>Arias</surname><given-names>J</given-names></name></person-group><article-title>Inflammation and cancer: is trophism the link?</article-title><source>Surg Oncol</source><year>2006</year><volume>15</volume><fpage>235</fpage><lpage>242</lpage><pub-id pub-id-type="pmid">17400443</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arias</surname><given-names>JI</given-names></name><name><surname>Aller</surname><given-names>MA</given-names></name><name><surname>Arias</surname><given-names>J</given-names></name></person-group><article-title>Cancer cell: using inflammation to invade the host</article-title><source>Mol Cancer</source><year>2007</year><volume>6</volume><fpage>29</fpage><pub-id pub-id-type="pmid">17437633</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aller</surname><given-names>MA</given-names></name><name><surname>Arias</surname><given-names>JL</given-names></name><name><surname>Nava</surname><given-names>MP</given-names></name><name><surname>Arias</surname><given-names>J</given-names></name></person-group><article-title>Evolutive trophic phases of the systemic acute inflammatory response, oxygen use mechanisms and metamorphosis</article-title><source>Psicothema</source><year>2004</year><volume>16</volume><fpage>369</fpage><lpage>372</lpage></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Selye</surname><given-names>H</given-names></name></person-group><article-title>The part of inflammation in the local adaptation syndrome</article-title><source>Rev Can Biol</source><year>1953</year><volume>12</volume><fpage>155</fpage><lpage>175</lpage><pub-id pub-id-type="pmid">13121623</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aller</surname><given-names>MA</given-names></name><name><surname>Arias</surname><given-names>JL</given-names></name><name><surname>Arias</surname><given-names>JI</given-names></name><name><surname>Sanchez-Patan</surname><given-names>F</given-names></name><name><surname>Arias</surname><given-names>J</given-names></name></person-group><article-title>The inflammatory response recapitulates phylogeny through trophic mechanisms to the injured tissue</article-title><source>Med Hypotheses</source><year>2007</year><volume>68</volume><fpage>202</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">16963191</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rhodes</surname><given-names>JM</given-names></name><name><surname>Simons</surname><given-names>M</given-names></name></person-group><article-title>The extracellular matrix and blood vessels formation: not just a scaffold</article-title><source>J Cell Mol Med</source><year>2007</year><volume>11</volume><fpage>176</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">17488472</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hynes</surname><given-names>RO</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name></person-group><article-title>The evolution of cell adhesion</article-title><source>J Cell Biol</source><year>2000</year><volume>150</volume><fpage>F89</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">10908592</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname><given-names>R</given-names></name><name><surname>Asari</surname><given-names>AA</given-names></name><name><surname>Sugahara</surname><given-names>KN</given-names></name></person-group><article-title>Hyaluronan fragments: an information-rich system</article-title><source>Eur J Cell Biol</source><year>2006</year><volume>85</volume><fpage>699</fpage><lpage>715</lpage><pub-id pub-id-type="pmid">16822580</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yung</surname><given-names>S</given-names></name><name><surname>Chan</surname><given-names>TM</given-names></name></person-group><article-title>Glycosaminoglycans and proteoglycans: overlooked entities?</article-title><source>Perit Dial Int</source><year>2007</year><volume>27</volume><fpage>S104</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">17556287</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Day</surname><given-names>AJ</given-names></name><name><surname>De la Motte</surname><given-names>CA</given-names></name></person-group><article-title>Hyaluronan cross-linking: a protective mechanism in inflammation?</article-title><source>TRENDS Immunol</source><year>2005</year><volume>26</volume><fpage>637</fpage><lpage>643</lpage><pub-id pub-id-type="pmid">16214414</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cantor</surname><given-names>JO</given-names></name><name><surname>Nadkarni</surname><given-names>PP</given-names></name></person-group><article-title>Hyaluronan: the Jekyll and Hyde molecule</article-title><source>Inflamm Allergy Drug Targets</source><year>2006</year><volume>5</volume><fpage>257</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">17168797</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bartlett</surname><given-names>AH</given-names></name><name><surname>Hayashida</surname><given-names>K</given-names></name><name><surname>Park</surname><given-names>PW</given-names></name></person-group><article-title>Molecular and cellular mechanisms of syndecans in tissue injury and inflammation</article-title><source>Mol Cells</source><year>2007</year><volume>24</volume><fpage>153</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">17978567</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>D</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Noble</surname><given-names>PW</given-names></name></person-group><article-title>Hyaluronan in tissue injury and repair</article-title><source>Ann Rev Cell Dev Biol</source><year>2007</year><volume>23</volume><fpage>435</fpage><lpage>461</lpage><pub-id pub-id-type="pmid">17506690</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Slott</surname><given-names>PA</given-names></name><name><surname>Liu</surname><given-names>MH</given-names></name><name><surname>Tavoloni</surname><given-names>N</given-names></name></person-group><article-title>Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat</article-title><source>Gastroenterology</source><year>1990</year><volume>99</volume><fpage>466</fpage><lpage>477</lpage><pub-id pub-id-type="pmid">1694804</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Desmouliere</surname><given-names>A</given-names></name><name><surname>Darby</surname><given-names>Z</given-names></name><name><surname>Costa</surname><given-names>AMA</given-names></name><name><surname>Raccurt</surname><given-names>M</given-names></name><name><surname>Tuchweber</surname><given-names>B</given-names></name><name><surname>Sommer</surname><given-names>P</given-names></name><name><surname>Gabbiani</surname><given-names>G</given-names></name></person-group><article-title>Extracellular matrix deposition, lysysoxidase expression and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat</article-title><source>Lab Invest</source><year>1997</year><volume>76</volume><fpage>765</fpage><lpage>778</lpage><pub-id pub-id-type="pmid">9194853</pub-id></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramm</surname><given-names>GA</given-names></name><name><surname>Carr</surname><given-names>SC</given-names></name><name><surname>Bridle</surname><given-names>KR</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Britton</surname><given-names>RS</given-names></name><name><surname>Crawford</surname><given-names>DH</given-names></name><name><surname>Vogler</surname><given-names>CA</given-names></name><name><surname>Bacon</surname><given-names>BR</given-names></name><name><surname>Tracy</surname><given-names>TF</given-names></name></person-group><article-title>Morphology of liver repair following cholestatic liver injury: resolution of ductal hyperplasia, matrix deposition and regression of myofibroblasts</article-title><source>Liver</source><year>2000</year><volume>20</volume><fpage>387</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">11092257</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>AM</given-names></name><name><surname>Tuchweber</surname><given-names>B</given-names></name><name><surname>Lamireau</surname><given-names>T</given-names></name><name><surname>Yousef</surname><given-names>IM</given-names></name><name><surname>Balabaud</surname><given-names>C</given-names></name><name><surname>Rosenbaum</surname><given-names>J</given-names></name><name><surname>Desmouliere</surname><given-names>A</given-names></name></person-group><article-title>Role of apoptosis in the remodeling of cholestatic liver injury following release of the mechanical stress</article-title><source>Virchows Arch</source><year>2003</year><volume>442</volume><fpage>372</fpage><lpage>380</lpage><pub-id pub-id-type="pmid">12715172</pub-id></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>KM</given-names></name><name><surname>Sabla</surname><given-names>GE</given-names></name><name><surname>Bezerra</surname><given-names>JA</given-names></name></person-group><article-title>Transcriptional reprogramming in murine liver defines the physiologic consequences of biliary obstruction</article-title><source>J Hepatol</source><year>2004</year><volume>40</volume><fpage>14</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">14672609</pub-id></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kojima</surname><given-names>K</given-names></name><name><surname>Hosokawa</surname><given-names>M</given-names></name><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Tainaka</surname><given-names>H</given-names></name><name><surname>Chiba</surname><given-names>K</given-names></name></person-group><article-title>Microarray analysis of hepatic gene expression during long-term cholestasis induced by common bile duct ligation in rats</article-title><source>Res Commun Mol Pathol Pharmacol</source><year>2004</year><volume>115&#x02013;116</volume><fpage>63</fpage><lpage>75</lpage></citation></ref><ref id="B56"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohara</surname><given-names>N</given-names></name><name><surname>Schaffner</surname><given-names>T</given-names></name><name><surname>Reichen</surname><given-names>J</given-names></name></person-group><article-title>Structure-function relationship in secondary biliary cirrhosis in the rat. Stereologic and hemodynamic characterization of a model</article-title><source>J Hepatol</source><year>1993</year><volume>17</volume><fpage>155</fpage><lpage>162</lpage><pub-id pub-id-type="pmid">8445230</pub-id></citation></ref><ref id="B57"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name></person-group><article-title>Research progress of vasculopathy in portal hypertension</article-title><source>World J Gastroenterol</source><year>2005</year><volume>11</volume><fpage>6079</fpage><lpage>6084</lpage><pub-id pub-id-type="pmid">16273630</pub-id></citation></ref><ref id="B58"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baron</surname><given-names>V</given-names></name><name><surname>Hernandez</surname><given-names>J</given-names></name><name><surname>Noyola</surname><given-names>M</given-names></name><name><surname>Escalante</surname><given-names>B</given-names></name><name><surname>Muriel</surname><given-names>P</given-names></name></person-group><article-title>Nitric oxide and inducible nitric oxyde synthase expression are downregulated in acute cholestasis in the rat accompanied by liver ischemia</article-title><source>Comp Biochem Physiol C Toxicol Pharmacol</source><year>2000</year><volume>127</volume><fpage>243</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">11246495</pub-id></citation></ref><ref id="B59"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gaudio</surname><given-names>E</given-names></name><name><surname>Onori</surname><given-names>P</given-names></name><name><surname>Pannarale</surname><given-names>L</given-names></name><name><surname>Alvaro</surname><given-names>D</given-names></name></person-group><article-title>Hepatic microcirculation and peribiliary plexus in experimental biliary cirrhosis: a morphology study</article-title><source>Gastroenterology</source><year>1996</year><volume>111</volume><fpage>1118</fpage><lpage>1124</lpage><pub-id pub-id-type="pmid">8831608</pub-id></citation></ref><ref id="B60"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>WG</given-names></name><name><surname>Hu</surname><given-names>SH</given-names></name><name><surname>Xue</surname><given-names>BD</given-names></name><name><surname>Jiang</surname><given-names>ZG</given-names></name><name><surname>Huang</surname><given-names>ZQ</given-names></name></person-group><article-title>Observation of hepatohilar peribiliary vascular plexus with complete absence of hepatic artery blood supply in rats</article-title><source>Transplant Proc</source><year>2007</year><volume>39</volume><fpage>3424</fpage><lpage>2428</lpage><pub-id pub-id-type="pmid">18089397</pub-id></citation></ref><ref id="B61"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lautt</surname><given-names>WW</given-names></name></person-group><article-title>Relationship between hepatic blood flow and overall metabolism: the hepatic arterial buffer response</article-title><source>Fed Proc</source><year>1983</year><volume>42</volume><fpage>1662</fpage><lpage>1666</lpage><pub-id pub-id-type="pmid">6832383</pub-id></citation></ref><ref id="B62"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Maher</surname><given-names>JM</given-names></name><name><surname>Klaassen</surname><given-names>CD</given-names></name></person-group><article-title>Kupffer cell-mediated downregulation of hepatic transporter expression in rat hepatic ischemia-reperfusion</article-title><source>Transplantation</source><year>2006</year><volume>82</volume><fpage>258</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">16858290</pub-id></citation></ref><ref id="B63"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tahan</surname><given-names>G</given-names></name><name><surname>Tarcin</surname><given-names>O</given-names></name><name><surname>Tahan</surname><given-names>V</given-names></name><name><surname>Eren</surname><given-names>F</given-names></name><name><surname>Gedik</surname><given-names>N</given-names></name><name><surname>Sahan</surname><given-names>E</given-names></name><name><surname>Biberoglu</surname><given-names>N</given-names></name><name><surname>Guzel</surname><given-names>S</given-names></name><name><surname>Bozbas</surname><given-names>A</given-names></name><name><surname>Tuzun</surname><given-names>N</given-names></name><name><surname>Yucel</surname><given-names>O</given-names></name></person-group><article-title>The effects of <italic>N</italic>-acetylcysteine on bile-duct ligation-induced liver fibrosis in rats</article-title><source>Dig Dis Sci</source><year>2007</year><volume>52</volume><fpage>3348</fpage><lpage>3354</lpage><pub-id pub-id-type="pmid">17436097</pub-id></citation></ref><ref id="B64"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Rajaraman</surname><given-names>G</given-names></name><name><surname>Roberts</surname><given-names>MS</given-names></name><name><surname>Gong</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>P</given-names></name><name><surname>Burczynski</surname><given-names>F</given-names></name></person-group><article-title>Expression and antioxidant function of liver fatty acid binding protein in normal and bile-duct ligated rats</article-title><source>Eur J Pharmacol</source><year>2007</year><volume>560</volume><fpage>61</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">17292345</pub-id></citation></ref><ref id="B65"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Orellana</surname><given-names>M</given-names></name><name><surname>Avalos</surname><given-names>N</given-names></name><name><surname>Abarca</surname><given-names>M</given-names></name><name><surname>Valdes</surname><given-names>E</given-names></name></person-group><article-title>Microsomal and peroxisomal fatty acid oxidation in bile duct ligated rats: a comparative study between liver and kidney</article-title><source>Gen Pharmacol</source><year>1997</year><volume>28</volume><fpage>525</fpage><lpage>529</lpage><pub-id pub-id-type="pmid">9147020</pub-id></citation></ref><ref id="B66"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Portincasa</surname><given-names>P</given-names></name><name><surname>Grattagliano</surname><given-names>I</given-names></name><name><surname>Testini</surname><given-names>M</given-names></name><name><surname>Caruso</surname><given-names>ML</given-names></name><name><surname>Wang</surname><given-names>DQH</given-names></name><name><surname>Moschetta</surname><given-names>A</given-names></name><name><surname>Calamita</surname><given-names>G</given-names></name><name><surname>Vacca</surname><given-names>M</given-names></name><name><surname>Valentini</surname><given-names>AM</given-names></name><name><surname>Renna</surname><given-names>G</given-names></name><name><surname>Lissidini</surname><given-names>G</given-names></name><name><surname>Palasciano</surname><given-names>G</given-names></name></person-group><article-title>Parallel intestinal and liver injury during early cholestasis in the rat: modulation by bile salts and antioxidants</article-title><source>Free Rad Biol Med</source><year>2007</year><volume>42</volume><fpage>1381</fpage><lpage>1391</lpage><pub-id pub-id-type="pmid">17395011</pub-id></citation></ref><ref id="B67"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Assimakopoulos</surname><given-names>SF</given-names></name><name><surname>Maroulis</surname><given-names>I</given-names></name><name><surname>Patsoukis</surname><given-names>N</given-names></name><name><surname>Vagenas</surname><given-names>K</given-names></name><name><surname>Scopa</surname><given-names>CD</given-names></name><name><surname>Georgiou</surname><given-names>CD</given-names></name><name><surname>Vagianos</surname><given-names>CE</given-names></name></person-group><article-title>Effect of antioxidant treatments on the gut-liver axis oxidative status and function in bile duct-ligated rats</article-title><source>World J Surg</source><year>2007</year><volume>31</volume><fpage>2023</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">17665241</pub-id></citation></ref><ref id="B68"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Assimakopoulos</surname><given-names>SF</given-names></name><name><surname>Vagianos</surname><given-names>CE</given-names></name><name><surname>Patsoukis</surname><given-names>N</given-names></name><name><surname>Georgiou</surname><given-names>C</given-names></name><name><surname>Nikolopoulou</surname><given-names>V</given-names></name><name><surname>Scopa</surname><given-names>CD</given-names></name></person-group><article-title>Evidence for intestinal oxidative stress in obstructive jaundice-induced gut barrier dysfunction in rats</article-title><source>Acta Physiol Scand</source><year>2004</year><volume>180</volume><fpage>177</fpage><lpage>185</lpage><pub-id pub-id-type="pmid">14738476</pub-id></citation></ref><ref id="B69"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soylu</surname><given-names>AR</given-names></name><name><surname>Aydogtu</surname><given-names>N</given-names></name><name><surname>Basaran</surname><given-names>UN</given-names></name><name><surname>Altaner</surname><given-names>S</given-names></name><name><surname>Tarcin</surname><given-names>O</given-names></name><name><surname>Gedik</surname><given-names>N</given-names></name><name><surname>Umit</surname><given-names>H</given-names></name><name><surname>Tezel</surname><given-names>A</given-names></name><name><surname>Dokmeci</surname><given-names>G</given-names></name><name><surname>Galoglu</surname><given-names>H</given-names></name><name><surname>Ture</surname><given-names>M</given-names></name><name><surname>Kutiu</surname><given-names>K</given-names></name><name><surname>Kaymak</surname><given-names>K</given-names></name></person-group><article-title>Antioxidants vitamine E and C attenuate hepatic fibrosis in biliary obstructed rats</article-title><source>World J Gastroenterol</source><year>2006</year><volume>12</volume><fpage>6835</fpage><lpage>6841</lpage><pub-id pub-id-type="pmid">17106933</pub-id></citation></ref><ref id="B70"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kennett</surname><given-names>EC</given-names></name><name><surname>Davies</surname><given-names>MJ</given-names></name></person-group><article-title>Degradation of matrix glycosaminoglycans by peroxynitrite/peroxynitrous acid: evidence for a hydroxyl-radical-like mechanism</article-title><source>Free Rad Biol Med</source><year>2007</year><volume>42</volume><fpage>1278</fpage><lpage>1289</lpage><pub-id pub-id-type="pmid">17382208</pub-id></citation></ref><ref id="B71"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Alberts</surname><given-names>B</given-names></name><name><surname>Bray</surname><given-names>D</given-names></name><name><surname>Lewis</surname><given-names>J</given-names></name><name><surname>Raff</surname><given-names>M</given-names></name><name><surname>Roberts</surname><given-names>K</given-names></name><name><surname>Watson</surname><given-names>JD</given-names></name></person-group><article-title>Molecular biology of the cell</article-title><source>Cell-cell adhesion and the extracellular matrix</source><year>1983</year><publisher-name>New York: Garland Publishing Inc</publisher-name><fpage>673</fpage><lpage>715</lpage></citation></ref><ref id="B72"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Fu</surname><given-names>B</given-names></name></person-group><article-title>A model for charged molecule transport in the interstitial space</article-title><source>Conf Proc IEEE Eng Med Biol Soc</source><year>2005</year><volume>1</volume><fpage>55</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">17282109</pub-id></citation></ref><ref id="B73"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Evanko</surname><given-names>SP</given-names></name><name><surname>Tammi</surname><given-names>MI</given-names></name><name><surname>Tammi</surname><given-names>RH</given-names></name><name><surname>Wight</surname><given-names>TN</given-names></name></person-group><article-title>Hyaluronan-dependent pericellular matrix</article-title><source>Adv Drug Deliv Rev</source><year>2007</year><volume>59</volume><fpage>1351</fpage><lpage>1365</lpage><pub-id pub-id-type="pmid">17804111</pub-id></citation></ref><ref id="B74"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ingber</surname><given-names>DE</given-names></name></person-group><article-title>Cellular mechanotransduction: putting all the pieces together again</article-title><source>FASEB J</source><year>2006</year><volume>20</volume><fpage>811</fpage><lpage>827</lpage><pub-id pub-id-type="pmid">16675838</pub-id></citation></ref><ref id="B75"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bischofs</surname><given-names>IB</given-names></name><name><surname>Schwarz</surname><given-names>US</given-names></name></person-group><article-title>Cell organization in soft media due to active mechanosensing</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><fpage>9274</fpage><lpage>9279</lpage><pub-id pub-id-type="pmid">12883003</pub-id></citation></ref><ref id="B76"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Georges</surname><given-names>PC</given-names></name><name><surname>Hui</surname><given-names>JJ</given-names></name><name><surname>Gombos</surname><given-names>Z</given-names></name><name><surname>McCormick</surname><given-names>ME</given-names></name><name><surname>Wang</surname><given-names>AY</given-names></name><name><surname>Uemura</surname><given-names>M</given-names></name><name><surname>Mick</surname><given-names>R</given-names></name><name><surname>Janmey</surname><given-names>PA</given-names></name><name><surname>Furth</surname><given-names>EE</given-names></name><name><surname>Wells</surname><given-names>RG</given-names></name></person-group><article-title>Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis</article-title><source>Am J Physiol Gastrointest Liver Physiol</source><year>2007</year><volume>293</volume><fpage>G1147</fpage><lpage>G1154</lpage><pub-id pub-id-type="pmid">17932231</pub-id></citation></ref><ref id="B77"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muddu</surname><given-names>AK</given-names></name><name><surname>Guha</surname><given-names>IN</given-names></name><name><surname>Elsharkawy</surname><given-names>AM</given-names></name><name><surname>Mann</surname><given-names>DA</given-names></name></person-group><article-title>Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic</article-title><source>Int J Biochem Cell Biol</source><year>2007</year><volume>39</volume><fpage>695</fpage><lpage>714</lpage><pub-id pub-id-type="pmid">17110155</pub-id></citation></ref><ref id="B78"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Winau</surname><given-names>F</given-names></name><name><surname>Quack</surname><given-names>C</given-names></name><name><surname>Darmoise</surname><given-names>A</given-names></name><name><surname>Kaufmann</surname><given-names>SHE</given-names></name></person-group><article-title>Starring stellate cells in liver immunology</article-title><source>Curr Opin Immunol</source><year>2008</year><volume>20</volume><fpage>68</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">18068343</pub-id></citation></ref><ref id="B79"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Azouz</surname><given-names>A</given-names></name><name><surname>Razzaque</surname><given-names>MS</given-names></name><name><surname>El-Hallak</surname><given-names>M</given-names></name><name><surname>Taguchi</surname><given-names>T</given-names></name></person-group><article-title>Immunoinflammatory responses and fibrogenesis</article-title><source>Med Electron Microsc</source><year>2004</year><volume>37</volume><fpage>141</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">15449105</pub-id></citation></ref><ref id="B80"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morwood</surname><given-names>SR</given-names></name><name><surname>Nicholson</surname><given-names>LB</given-names></name></person-group><article-title>Modulation of the immune response by extracellular matrix proteins</article-title><source>Arch Immunol Ther Exp (Warsz)</source><year>2006</year><volume>54</volume><fpage>367</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">17122884</pub-id></citation></ref><ref id="B81"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Szabo</surname><given-names>G</given-names></name><name><surname>Mandrakar</surname><given-names>P</given-names></name><name><surname>Dolganiuc</surname><given-names>A</given-names></name></person-group><article-title>Innate immune response and hepatic inflammation</article-title><source>Semin Liver Dis</source><year>2007</year><volume>27</volume><fpage>339</fpage><lpage>350</lpage><pub-id pub-id-type="pmid">17979071</pub-id></citation></ref><ref id="B82"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cuenca</surname><given-names>J</given-names></name><name><surname>Martin-Sanz</surname><given-names>P</given-names></name><name><surname>Alvarez-Barrientos</surname><given-names>AM</given-names></name><name><surname>Bosca</surname><given-names>L</given-names></name><name><surname>Goren</surname><given-names>N</given-names></name></person-group><article-title>Infiltration of inflammatory cells plays an important role in matrix metalloproteinase expression and activation in the heart during sepsis</article-title><source>Am J Pathol</source><year>2006</year><volume>169</volume><fpage>1567</fpage><lpage>1576</lpage><pub-id pub-id-type="pmid">17071581</pub-id></citation></ref><ref id="B83"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roeb</surname><given-names>E</given-names></name><name><surname>Purucker</surname><given-names>E</given-names></name><name><surname>Breuer</surname><given-names>B</given-names></name><name><surname>Nguyen</surname><given-names>H</given-names></name><name><surname>Heinrich</surname><given-names>PC</given-names></name><name><surname>Rose-John</surname><given-names>S</given-names></name><name><surname>Matern</surname><given-names>S</given-names></name></person-group><article-title>TIMP expression in toxic and cholestatic liver injury in rat</article-title><source>J Hepatol</source><year>1997</year><volume>27</volume><fpage>535</fpage><lpage>544</lpage><pub-id pub-id-type="pmid">9314132</pub-id></citation></ref><ref id="B84"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bergheim</surname><given-names>I</given-names></name><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>Davis</surname><given-names>MA</given-names></name><name><surname>Duveau</surname><given-names>I</given-names></name><name><surname>Arteel</surname><given-names>GE</given-names></name></person-group><article-title>Critical role of palsminogen activator inhibitor-1 in cholestatic liver injury and fibrosis</article-title><source>J Pharmacol Exp Ther</source><year>2006</year><volume>316</volume><fpage>592</fpage><lpage>600</lpage><pub-id pub-id-type="pmid">16221737</pub-id></citation></ref><ref id="B85"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kolios</surname><given-names>G</given-names></name><name><surname>Valatas</surname><given-names>V</given-names></name><name><surname>Kouroumalis</surname><given-names>E</given-names></name></person-group><article-title>Role of Kupffer cells in the pathogenesis of liver disease</article-title><source>World J Gastroenterol</source><year>2006</year><volume>12</volume><fpage>7413</fpage><lpage>7420</lpage><pub-id pub-id-type="pmid">17167827</pub-id></citation></ref><ref id="B86"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Minter</surname><given-names>RM</given-names></name><name><surname>Fan</surname><given-names>MH</given-names></name><name><surname>Niederbichler</surname><given-names>A</given-names></name><name><surname>Ipaktchi</surname><given-names>K</given-names></name><name><surname>Arabi</surname><given-names>S</given-names></name><name><surname>Hemmila</surname><given-names>MR</given-names></name><name><surname>Remick</surname><given-names>DG</given-names></name><name><surname>Wang</surname><given-names>SC</given-names></name><name><surname>Su</surname><given-names>GL</given-names></name></person-group><article-title>Altered Kupffer cell function in biliary obstruction</article-title><source>Surgery</source><year>2005</year><volume>138</volume><fpage>236</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">16153432</pub-id></citation></ref><ref id="B87"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>O'Neil</surname><given-names>S</given-names></name><name><surname>Hunt</surname><given-names>J</given-names></name><name><surname>Filkins</surname><given-names>J</given-names></name><name><surname>Gamelli</surname><given-names>R</given-names></name></person-group><article-title>Obstructive jaundice in rats results in exaggerated hepatic production of tumor necrosis factor-alpha and tissue tumor necrosis factor-alpha levels after endotoxin</article-title><source>Surgery</source><year>1997</year><volume>122</volume><fpage>281</fpage><lpage>286</lpage><pub-id pub-id-type="pmid">9288133</pub-id></citation></ref><ref id="B88"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harry</surname><given-names>D</given-names></name><name><surname>Anand</surname><given-names>R</given-names></name><name><surname>Holt</surname><given-names>S</given-names></name><name><surname>Davies</surname><given-names>S</given-names></name><name><surname>Marley</surname><given-names>R</given-names></name><name><surname>Fernando</surname><given-names>B</given-names></name><name><surname>Goodier</surname><given-names>D</given-names></name><name><surname>Moore</surname><given-names>K</given-names></name></person-group><article-title>Increased sensitivity to endotoxemia in the bile duct-ligated cirrhotic rat</article-title><source>Hepatology</source><year>1999</year><volume>30</volume><fpage>1198</fpage><lpage>1205</lpage><pub-id pub-id-type="pmid">10534341</pub-id></citation></ref><ref id="B89"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moazzam</surname><given-names>FN</given-names></name><name><surname>Brems</surname><given-names>JJ</given-names></name><name><surname>Yong</surname><given-names>SL</given-names></name><name><surname>Filkins</surname><given-names>JP</given-names></name><name><surname>Fisher</surname><given-names>SG</given-names></name><name><surname>Holt</surname><given-names>DR</given-names></name><name><surname>Gamalli</surname><given-names>RL</given-names></name><name><surname>Ding</surname><given-names>JW</given-names></name></person-group><article-title>Endotoxin potentiates hepatocyte apoptosis in cholestasis</article-title><source>J Am Coll Surg</source><year>2002</year><volume>194</volume><fpage>731</fpage><lpage>739</lpage><pub-id pub-id-type="pmid">12081063</pub-id></citation></ref><ref id="B90"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gehring</surname><given-names>S</given-names></name><name><surname>Dickson</surname><given-names>EM</given-names></name><name><surname>San Martin</surname><given-names>ME</given-names></name><name><surname>Van Rooijen</surname><given-names>N</given-names></name><name><surname>Papa</surname><given-names>EF</given-names></name><name><surname>Harty</surname><given-names>MW</given-names></name><name><surname>Tracy</surname><given-names>TF</given-names></name><name><surname>Gregory</surname><given-names>SH</given-names></name></person-group><article-title>Kupffer cells abrogate cholestatic liver injury in mice</article-title><source>Gastroenterology</source><year>2006</year><volume>130</volume><fpage>810</fpage><lpage>822</lpage><pub-id pub-id-type="pmid">16530521</pub-id></citation></ref><ref id="B91"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thabut</surname><given-names>D</given-names></name><name><surname>Tzai</surname><given-names>KA</given-names></name><name><surname>Bonnefont-Rousselot</surname><given-names>D</given-names></name><name><surname>Aller</surname><given-names>M</given-names></name><name><surname>Farges</surname><given-names>O</given-names></name><name><surname>Guimont</surname><given-names>MC</given-names></name><name><surname>Tellier</surname><given-names>Z</given-names></name><name><surname>Guicharo</surname><given-names>C</given-names></name><name><surname>Ogier-Denis</surname><given-names>E</given-names></name><name><surname>Poynard</surname><given-names>T</given-names></name><name><surname>Moureau</surname><given-names>R</given-names></name><name><surname>Le Brec</surname><given-names>D</given-names></name></person-group><article-title>High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats</article-title><source>Hepatology</source><year>2007</year><volume>46</volume><fpage>1893</fpage><lpage>1906</lpage><pub-id pub-id-type="pmid">17918268</pub-id></citation></ref><ref id="B92"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shivakumar</surname><given-names>P</given-names></name><name><surname>Campbell</surname><given-names>KH</given-names></name><name><surname>Sabla</surname><given-names>GE</given-names></name><name><surname>Miethke</surname><given-names>A</given-names></name><name><surname>Tiao</surname><given-names>G</given-names></name><name><surname>McNeal</surname><given-names>MM</given-names></name><name><surname>Ward</surname><given-names>RL</given-names></name><name><surname>Bezerra</surname><given-names>JA</given-names></name></person-group><article-title>Obstructive of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia</article-title><source>J Clin Invest</source><year>2004</year><volume>114</volume><fpage>322</fpage><lpage>329</lpage><pub-id pub-id-type="pmid">15286798</pub-id></citation></ref><ref id="B93"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Georgiev</surname><given-names>P</given-names></name><name><surname>Jochum</surname><given-names>W</given-names></name><name><surname>Heinrich</surname><given-names>S</given-names></name><name><surname>Jang</surname><given-names>JH</given-names></name><name><surname>Nocito</surname><given-names>A</given-names></name><name><surname>Dahm</surname><given-names>F</given-names></name><name><surname>Clavien</surname><given-names>PA</given-names></name></person-group><article-title>Characterization of time-related changes after experimental bile duct ligation</article-title><source>Br J Surg</source><year>2008</year><volume>95</volume><fpage>646</fpage><lpage>56</lpage><pub-id pub-id-type="pmid">18196571</pub-id></citation></ref><ref id="B94"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>R</given-names></name><name><surname>Schlaeffe</surname><given-names>F</given-names></name><name><surname>Keynan</surname><given-names>A</given-names></name><name><surname>Nagauker</surname><given-names>O</given-names></name><name><surname>Yaari</surname><given-names>A</given-names></name><name><surname>Sikuler</surname><given-names>E</given-names></name></person-group><article-title>Increased neutrophil function induced by bile duct ligation in a rat model</article-title><source>Hepatology</source><year>1993</year><volume>17</volume><fpage>908</fpage><lpage>914</lpage><pub-id pub-id-type="pmid">8387951</pub-id></citation></ref><ref id="B95"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fernandez-Martinez</surname><given-names>E</given-names></name><name><surname>Perez-Alvarez</surname><given-names>V</given-names></name><name><surname>Tsutsumi</surname><given-names>V</given-names></name><name><surname>Shibayama</surname><given-names>M</given-names></name><name><surname>Muriel</surname><given-names>P</given-names></name></person-group><article-title>Chronic bile duct obstruction induces changes in plasma and hepatic levels of cytokines and nitric oxide in the rat</article-title><source>Exp Toxicol Pathol</source><year>2006</year><volume>58</volume><fpage>49</fpage><lpage>58</lpage><pub-id pub-id-type="pmid">16617007</pub-id></citation></ref><ref id="B96"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Donner</surname><given-names>MG</given-names></name><name><surname>Schumacher</surname><given-names>S</given-names></name><name><surname>Warskulat</surname><given-names>U</given-names></name><name><surname>Heinehann</surname><given-names>J</given-names></name><name><surname>H&#x000e4;ussinger</surname><given-names>D</given-names></name></person-group><article-title>Obstructive cholestasis induces TNF-&#x003b1; and IL-1&#x003b2;-mediated periportal downregulation of Bsep and zonal regulation of Ntcp, Oatp1a4, and Oatp1b2</article-title><source>Am J Physiol Gastroenterol Liver Physiol</source><year>2007</year><volume>293</volume><fpage>G1134</fpage><lpage>G1146</lpage></citation></ref><ref id="B97"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rockey</surname><given-names>D</given-names></name></person-group><article-title>Hepatic fibrosis, stellate cells, and portal hypertension</article-title><source>Clin Liver Dis</source><year>2006</year><volume>10</volume><fpage>459</fpage><lpage>479</lpage><pub-id pub-id-type="pmid">17162223</pub-id></citation></ref><ref id="B98"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gressner</surname><given-names>OA</given-names></name><name><surname>Weiskirchen</surname><given-names>R</given-names></name><name><surname>Gressner</surname><given-names>AM</given-names></name></person-group><article-title>Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options</article-title><source>Comp Hepatol</source><year>2007</year><volume>6</volume><fpage>7</fpage><pub-id pub-id-type="pmid">17663771</pub-id></citation></ref><ref id="B99"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Tsao</surname><given-names>G</given-names></name><name><surname>Wiest</surname><given-names>R</given-names></name></person-group><article-title>Gut microflora in the pathogenesis of the complications of cirrhosis</article-title><source>Best Pract Res Clin Gastroenterol</source><year>2004</year><volume>18</volume><fpage>353</fpage><lpage>372</lpage><pub-id pub-id-type="pmid">15123075</pub-id></citation></ref><ref id="B100"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sztrymf</surname><given-names>B</given-names></name><name><surname>Libert</surname><given-names>JM</given-names></name><name><surname>Mougeot</surname><given-names>C</given-names></name><name><surname>Lebrec</surname><given-names>D</given-names></name><name><surname>Mazmanian</surname><given-names>M</given-names></name><name><surname>Humbert</surname><given-names>M</given-names></name><name><surname>Herve</surname><given-names>P</given-names></name></person-group><article-title>Cirrhotic rats with bacterial translocation have higher incidence and severity of hepatopulmonary syndrome</article-title><source>J Gastroenterol Hepatol</source><year>2005</year><volume>20</volume><fpage>1538</fpage><lpage>1544</lpage><pub-id pub-id-type="pmid">16174071</pub-id></citation></ref><ref id="B101"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Frances</surname><given-names>R</given-names></name><name><surname>Chiva</surname><given-names>M</given-names></name><name><surname>S&#x000e1;nchez</surname><given-names>E</given-names></name><name><surname>Gonzalez-Navajas</surname><given-names>JM</given-names></name><name><surname>Llovet</surname><given-names>T</given-names></name><name><surname>Zapater</surname><given-names>P</given-names></name><name><surname>Soriano</surname><given-names>G</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>C</given-names></name><name><surname>Balaz&#x000f3;</surname><given-names>J</given-names></name><name><surname>Perez-Mateo</surname><given-names>M</given-names></name><name><surname>Song</surname><given-names>X-Y</given-names></name><name><surname>Guarner</surname><given-names>C</given-names></name><name><surname>Such</surname><given-names>J</given-names></name></person-group><article-title>Bacterial translocation is downregulated by anti-TNF-&#x003b1; monoclonal antibody administration in rats with cirrhosis and ascites</article-title><source>J Hepatol</source><year>2007</year><volume>46</volume><fpage>797</fpage><lpage>803</lpage><pub-id pub-id-type="pmid">17321632</pub-id></citation></ref><ref id="B102"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morita</surname><given-names>Y</given-names></name><name><surname>Yoshidome</surname><given-names>H</given-names></name><name><surname>Kimura</surname><given-names>F</given-names></name><name><surname>Shimizu</surname><given-names>H</given-names></name><name><surname>Ohtsuka</surname><given-names>M</given-names></name><name><surname>Taxeuchi</surname><given-names>D</given-names></name><name><surname>Mitsuhashi</surname><given-names>N</given-names></name><name><surname>Iida</surname><given-names>A</given-names></name><name><surname>Miyazaki</surname><given-names>M</given-names></name></person-group><article-title>Excessive inflammation but decreased immunological response renders liver susceptible to infection in bile duct ligated mice</article-title><source>J Surg Res</source><year>2008</year><volume>146</volume><fpage>262</fpage><lpage>270</lpage><pub-id pub-id-type="pmid">18061617</pub-id></citation></ref><ref id="B103"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rioux</surname><given-names>KP</given-names></name><name><surname>Sharkey</surname><given-names>KA</given-names></name><name><surname>Wallace</surname><given-names>JL</given-names></name><name><surname>Swain</surname><given-names>MG</given-names></name></person-group><article-title>Hepatic mucosal mast cell hyperplasia in rats with secondary biliary cirrhosis</article-title><source>Hepatology</source><year>1996</year><volume>23</volume><fpage>888</fpage><lpage>895</lpage><pub-id pub-id-type="pmid">8666346</pub-id></citation></ref><ref id="B104"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schramm</surname><given-names>R</given-names></name><name><surname>Thorlacius</surname><given-names>H</given-names></name></person-group><article-title>Neutrophil recruitment in mast cell-dependent inflammation: inhibitory mechanisms of glucocorticoids</article-title><source>Inflamm Res</source><year>2004</year><volume>53</volume><fpage>644</fpage><lpage>652</lpage><pub-id pub-id-type="pmid">15654511</pub-id></citation></ref><ref id="B105"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takeshita</surname><given-names>A</given-names></name><name><surname>Shibayama</surname><given-names>Y</given-names></name></person-group><article-title>Role of mast cells in hepatic remodeling during cholestasis and its resolution: relevance to regulation of apoptosis</article-title><source>Exp Toxicol Pathol</source><year>2005</year><volume>56</volume><fpage>273</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">15816356</pub-id></citation></ref><ref id="B106"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Franceschini</surname><given-names>B</given-names></name><name><surname>Ceva-Grimaldi</surname><given-names>G</given-names></name><name><surname>Russo</surname><given-names>C</given-names></name><name><surname>Dioguardi</surname><given-names>N</given-names></name><name><surname>Grizzi</surname><given-names>F</given-names></name></person-group><article-title>The complex functions of mast cells in chronic human liver diseases</article-title><source>Dig Dis Sci</source><year>2006</year><volume>51</volume><fpage>2248</fpage><lpage>2256</lpage><pub-id pub-id-type="pmid">17103041</pub-id></citation></ref><ref id="B107"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cabillic</surname><given-names>F</given-names></name><name><surname>Rougier</surname><given-names>N</given-names></name><name><surname>Basset</surname><given-names>C</given-names></name><name><surname>Lecovillard</surname><given-names>I</given-names></name><name><surname>Quelvennec</surname><given-names>E</given-names></name><name><surname>Tojas</surname><given-names>L</given-names></name><name><surname>Guguen-Guilouzon</surname><given-names>C</given-names></name><name><surname>Corlu</surname><given-names>A</given-names></name></person-group><article-title>Hepatic environment elicits monocyte differentiation into a dendritic cell subset directing Th2 response</article-title><source>J Hepatol</source><year>2006</year><volume>44</volume><fpage>552</fpage><lpage>559</lpage><pub-id pub-id-type="pmid">16310277</pub-id></citation></ref><ref id="B108"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Samuel</surname><given-names>I</given-names></name></person-group><article-title>Bile and pancreatic juice exclusion activates acinar stress kinases and exacerbates gallstone pancreatitis</article-title><source>Surgery</source><year>2008</year><volume>143</volume><fpage>434</fpage><lpage>440</lpage><pub-id pub-id-type="pmid">18291265</pub-id></citation></ref><ref id="B109"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Waseem</surname><given-names>T</given-names></name><name><surname>Duxbury</surname><given-names>M</given-names></name><name><surname>Ito</surname><given-names>H</given-names></name><name><surname>Ashley</surname><given-names>SW</given-names></name><name><surname>Robinson</surname><given-names>MK</given-names></name></person-group><article-title>Exogenous ghrelin modulates release of pro-inflammatory and anti-inflammatory cytokines in LPS-stimulated macrophages through distinct signaling pathways</article-title><source>Surgery</source><year>2008</year><volume>143</volume><fpage>334</fpage><lpage>342</lpage><pub-id pub-id-type="pmid">18291254</pub-id></citation></ref><ref id="B110"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>R</given-names></name><name><surname>McDonagh</surname><given-names>AF</given-names></name></person-group><article-title>The enzymatic formation of bilirubin</article-title><source>Ann NY Acad Sci</source><year>1975</year><volume>244</volume><fpage>533</fpage><lpage>552</lpage><pub-id pub-id-type="pmid">1094885</pub-id></citation></ref><ref id="B111"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vitek</surname><given-names>L</given-names></name><name><surname>Schwertner</surname><given-names>HA</given-names></name></person-group><article-title>The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases</article-title><source>Adv Clin Chem</source><year>2007</year><volume>43</volume><fpage>1</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">17249379</pub-id></citation></ref><ref id="B112"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bulmer</surname><given-names>AC</given-names></name><name><surname>Ried</surname><given-names>K</given-names></name><name><surname>Blanchfield</surname><given-names>JT</given-names></name><name><surname>Wagner</surname><given-names>KH</given-names></name></person-group><article-title>The anti-mutagenic properties of bile pigments</article-title><source>Mutat Res</source><year>2007</year><volume>658</volume><fpage>28</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">17602853</pub-id></citation></ref><ref id="B113"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Selye</surname><given-names>H</given-names></name></person-group><article-title>On the mechanism through which obstructive jaundice influences inflammatory processes</article-title><source>Ann Rheum Dis</source><year>1954</year><volume>13</volume><fpage>102</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">13171803</pub-id></citation></ref><ref id="B114"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moseley</surname><given-names>RH</given-names></name></person-group><article-title>Sepsis and cholestasis</article-title><source>Clin Liver Dis</source><year>1999</year><volume>3</volume><fpage>465</fpage><lpage>475</lpage><pub-id pub-id-type="pmid">11291234</pub-id></citation></ref><ref id="B115"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marrero</surname><given-names>J</given-names></name><name><surname>Martinez</surname><given-names>FJ</given-names></name><name><surname>Hyzy</surname><given-names>R</given-names></name></person-group><article-title>Advances in critical care hepatology</article-title><source>Am J Respir Crit Care Med</source><year>2003</year><volume>168</volume><fpage>1421</fpage><lpage>1426</lpage><pub-id pub-id-type="pmid">14668256</pub-id></citation></ref><ref id="B116"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kurz</surname><given-names>H</given-names></name><name><surname>Burri</surname><given-names>PH</given-names></name><name><surname>Djonov</surname><given-names>VG</given-names></name></person-group><article-title>Angiogenesis and vascular remodeling by intussusception: from form to function</article-title><source>News Physiol Sci</source><year>2003</year><volume>18</volume><fpage>65</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">12644622</pub-id></citation></ref><ref id="B117"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aller</surname><given-names>MA</given-names></name><name><surname>Arias</surname><given-names>JL</given-names></name><name><surname>Arias</surname><given-names>J</given-names></name></person-group><article-title>The mast cell integrates the splanchnic and systemic inflammatory response in portal hypertension</article-title><source>J Transl Med</source><year>2007</year><volume>5</volume><fpage>44</fpage><pub-id pub-id-type="pmid">17892556</pub-id></citation></ref><ref id="B118"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aller</surname><given-names>MA</given-names></name><name><surname>Arias</surname><given-names>JL</given-names></name><name><surname>Cruz</surname><given-names>A</given-names></name><name><surname>Arias</surname><given-names>J</given-names></name></person-group><article-title>Inflammation: a way to understanding the evolution of portal hypertension</article-title><source>Theor Biol Med Model</source><year>2007</year><volume>4</volume><fpage>44</fpage><pub-id pub-id-type="pmid">17999758</pub-id></citation></ref><ref id="B119"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gaudio</surname><given-names>E</given-names></name><name><surname>Barbaro</surname><given-names>B</given-names></name><name><surname>Alvaro</surname><given-names>D</given-names></name><name><surname>Glaser</surname><given-names>S</given-names></name><name><surname>Francis</surname><given-names>H</given-names></name><name><surname>Franchitto</surname><given-names>A</given-names></name><name><surname>Onori</surname><given-names>P</given-names></name><name><surname>Ueno</surname><given-names>Y</given-names></name><name><surname>Marzioni</surname><given-names>M</given-names></name><name><surname>Fava</surname><given-names>G</given-names></name><name><surname>Venter</surname><given-names>J</given-names></name><name><surname>Reichenbach</surname><given-names>R</given-names></name><name><surname>Summers</surname><given-names>R</given-names></name><name><surname>Alpini</surname><given-names>G</given-names></name></person-group><article-title>Administration of r-VEGF-A prevents hepatic artery ligation-induced bile duct damage in bile duct ligated rats</article-title><source>Am J Physiol Gastrointest Liver Physiol</source><year>2006</year><volume>291</volume><fpage>G307</fpage><lpage>G317</lpage><pub-id pub-id-type="pmid">16574985</pub-id></citation></ref><ref id="B120"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heuvel</surname><given-names>MC Van Den</given-names></name><name><surname>Gouw</surname><given-names>ASH</given-names></name><name><surname>Boot</surname><given-names>M</given-names></name><name><surname>Slooff</surname><given-names>MJH</given-names></name><name><surname>Poppema</surname><given-names>S</given-names></name><name><surname>De Jong</surname><given-names>KP</given-names></name></person-group><article-title>The finest branches of the biliary tree might induce biliary vascularization necessary for biliary regeneration</article-title><source>J Hepatol</source><year>2006</year><volume>44</volume><fpage>947</fpage><lpage>955</lpage><pub-id pub-id-type="pmid">16310280</pub-id></citation></ref><ref id="B121"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hynes</surname><given-names>RO</given-names></name></person-group><article-title>Integrins: bidirectional allosteric signalling machines</article-title><source>Cell</source><year>2002</year><volume>110</volume><fpage>673</fpage><lpage>687</lpage><pub-id pub-id-type="pmid">12297042</pub-id></citation></ref><ref id="B122"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanchez-Patan</surname><given-names>F</given-names></name><name><surname>Anchuelo</surname><given-names>R</given-names></name><name><surname>Corcuera</surname><given-names>MT</given-names></name><name><surname>Casado</surname><given-names>I</given-names></name><name><surname>Gomez- Aguado</surname><given-names>F</given-names></name><name><surname>Aller</surname><given-names>MA</given-names></name><name><surname>Cruz</surname><given-names>A</given-names></name><name><surname>Alonso</surname><given-names>MJ</given-names></name><name><surname>Arias</surname><given-names>J</given-names></name></person-group><article-title>Biliary fibrosis in microsurgical extrahepatic cholestasis in the rat</article-title><source>Microsurgery</source><year>2008</year><volume>28</volume><fpage>361</fpage><lpage>366</lpage><pub-id pub-id-type="pmid">18561272</pub-id></citation></ref><ref id="B123"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aube</surname><given-names>C</given-names></name><name><surname>Moal</surname><given-names>F</given-names></name><name><surname>Oberti</surname><given-names>F</given-names></name><name><surname>Roux</surname><given-names>J</given-names></name><name><surname>Croquet</surname><given-names>V</given-names></name><name><surname>Gallois</surname><given-names>Y</given-names></name><name><surname>Argand</surname><given-names>C</given-names></name><name><surname>Caron</surname><given-names>C</given-names></name><name><surname>Cales</surname><given-names>P</given-names></name></person-group><article-title>Diagnosis and measurement of liver fibrosis by MRI in bile duct ligated rats</article-title><source>Dig Dis Sci</source><year>2007</year><volume>52</volume><fpage>2601</fpage><lpage>2609</lpage><pub-id pub-id-type="pmid">17429735</pub-id></citation></ref><ref id="B124"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kershenobich</surname><given-names>SD</given-names></name><name><surname>Weissbrod</surname><given-names>AB</given-names></name></person-group><article-title>Liver fibrosis and inflammation. A review</article-title><source>Ann Hepatol</source><year>2003</year><volume>2</volume><fpage>159</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">15115954</pub-id></citation></ref><ref id="B125"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>MK</given-names></name><name><surname>Crawford</surname><given-names>JM</given-names></name></person-group><article-title>The pathology of cholestasis</article-title><source>Sem Liver Dis</source><year>2004</year><volume>24</volume><fpage>21</fpage><lpage>42</lpage></citation></ref><ref id="B126"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Proell</surname><given-names>V</given-names></name><name><surname>Carmona-Cuenca</surname><given-names>I</given-names></name><name><surname>Murillo</surname><given-names>MM</given-names></name><name><surname>Huber</surname><given-names>H</given-names></name><name><surname>Fabregat</surname><given-names>I</given-names></name><name><surname>Mikulits</surname><given-names>W</given-names></name></person-group><article-title>TGF-&#x003b2; dependent regulation of oxygen radicals during transdifferentiation of activated hepatic stellate cells to myofibroblastoid cells</article-title><source>Comp Hepatol</source><year>2007</year><volume>6</volume><fpage>1</fpage><pub-id pub-id-type="pmid">17311678</pub-id></citation></ref><ref id="B127"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sedlaczek</surname><given-names>N</given-names></name><name><surname>Jia</surname><given-names>JD</given-names></name><name><surname>Bauer</surname><given-names>M</given-names></name><name><surname>Herbst</surname><given-names>H</given-names></name><name><surname>Ruehl</surname><given-names>M</given-names></name><name><surname>Hahn</surname><given-names>EG</given-names></name><name><surname>Schuppan</surname><given-names>D</given-names></name></person-group><article-title>Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis</article-title><source>Am J Pathol</source><year>2001</year><volume>158</volume><fpage>1239</fpage><lpage>1244</lpage><pub-id pub-id-type="pmid">11290541</pub-id></citation></ref><ref id="B128"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cassiman</surname><given-names>D</given-names></name><name><surname>Libbrecht</surname><given-names>L</given-names></name><name><surname>Desmet</surname><given-names>V</given-names></name><name><surname>De Nef</surname><given-names>C</given-names></name><name><surname>Roskams</surname><given-names>T</given-names></name></person-group><article-title>Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers</article-title><source>J Hepatol</source><year>2002</year><volume>36</volume><fpage>200</fpage><lpage>209</lpage><pub-id pub-id-type="pmid">11830331</pub-id></citation></ref><ref id="B129"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sicklick</surname><given-names>JK</given-names></name><name><surname>Choi</surname><given-names>SS</given-names></name><name><surname>Bustamante</surname><given-names>M</given-names></name><name><surname>McCall</surname><given-names>SJ</given-names></name><name><surname>Hernandez-Perez</surname><given-names>E</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Y-X</given-names></name><name><surname>Rojkind</surname><given-names>M</given-names></name><name><surname>Diehl</surname><given-names>AM</given-names></name></person-group><article-title>Evidence for epithelial-mesenchymal transitions in adult liver cells</article-title><source>Am J Physiol Gastrointest Liver Physiol</source><year>2006</year><volume>291</volume><fpage>G575</fpage><lpage>G583</lpage><pub-id pub-id-type="pmid">16710052</pub-id></citation></ref><ref id="B130"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zimmermann</surname><given-names>A</given-names></name><name><surname>Zhao</surname><given-names>D</given-names></name><name><surname>Reichen</surname><given-names>J</given-names></name></person-group><article-title>Myofibroblasts in the cirrhotic rat liver reflect hepatic remodeling and correlate with fibrosis and sinusoidal capillarization</article-title><source>J Hepatol</source><year>1999</year><volume>30</volume><fpage>646</fpage><lpage>652</lpage><pub-id pub-id-type="pmid">10207806</pub-id></citation></ref><ref id="B131"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harty</surname><given-names>MW</given-names></name><name><surname>Papa</surname><given-names>EF</given-names></name><name><surname>Huddleston</surname><given-names>HM</given-names></name><name><surname>Young</surname><given-names>E</given-names></name><name><surname>Nazaret</surname><given-names>S</given-names></name><name><surname>Riley</surname><given-names>CA</given-names></name><name><surname>Ramm</surname><given-names>GA</given-names></name><name><surname>Gregory</surname><given-names>SH</given-names></name><name><surname>Tracy</surname><given-names>TF</given-names></name></person-group><article-title>Hepatic macrophages promote the neutrophil-dependent resolution of repairing cholestatic rat livers</article-title><source>Surgery</source><year>2008</year><volume>143</volume><fpage>667</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">18436015</pub-id></citation></ref><ref id="B132"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kilicoglu</surname><given-names>B</given-names></name><name><surname>Gencay</surname><given-names>C</given-names></name><name><surname>Kismet</surname><given-names>K</given-names></name><name><surname>Kilicoglu</surname><given-names>SS</given-names></name><name><surname>Erguder</surname><given-names>I</given-names></name><name><surname>Erel</surname><given-names>S</given-names></name><name><surname>Sunay</surname><given-names>AE</given-names></name><name><surname>Erdemli</surname><given-names>E</given-names></name><name><surname>Durak</surname><given-names>I</given-names></name><name><surname>Akkus</surname><given-names>AM</given-names></name></person-group><article-title>The ultrastructural research of liver in experimental obstructive jaundice and effect of honey</article-title><source>Am J Surg</source><year>2008</year><volume>195</volume><fpage>249</fpage><lpage>256</lpage><pub-id pub-id-type="pmid">18083132</pub-id></citation></ref><ref id="B133"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Black</surname><given-names>DM</given-names></name><name><surname>Behrns</surname><given-names>KE</given-names></name></person-group><article-title>A scientist revisits the atrophy-hypertrophy complex: Hepatic apoptosis and regeneration</article-title><source>Surg Oncol Clin N Am</source><year>2002</year><volume>11</volume><fpage>849</fpage><lpage>864</lpage><pub-id pub-id-type="pmid">12607575</pub-id></citation></ref><ref id="B134"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boger</surname><given-names>PT</given-names></name><name><surname>Larusso</surname><given-names>NF</given-names></name></person-group><article-title>Cholangiocyte biology</article-title><source>Curr Opin Gastroenterol</source><year>2007</year><volume>23</volume><fpage>299</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">17414846</pub-id></citation></ref><ref id="B135"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname><given-names>X</given-names></name><name><surname>Francis</surname><given-names>H</given-names></name><name><surname>Glaser</surname><given-names>S</given-names></name><name><surname>Alpini</surname><given-names>G</given-names></name><name><surname>Lesage</surname><given-names>G</given-names></name></person-group><article-title>Bile acid interactions with cholangiocytes</article-title><source>World J Gastroenterol</source><year>2006</year><volume>12</volume><fpage>3553</fpage><lpage>3563</lpage><pub-id pub-id-type="pmid">16773712</pub-id></citation></ref><ref id="B136"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marzioni</surname><given-names>M</given-names></name><name><surname>Fava</surname><given-names>G</given-names></name><name><surname>Benedetti</surname><given-names>A</given-names></name></person-group><article-title>Nervous and neuroendocrine regulation of the pathophysiology of cholestasis and of biliary carcinogenesis</article-title><source>World J Gastroenterol</source><year>2006</year><volume>12</volume><fpage>3471</fpage><lpage>3480</lpage><pub-id pub-id-type="pmid">16773704</pub-id></citation></ref><ref id="B137"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marzioni</surname><given-names>M</given-names></name><name><surname>Glaser</surname><given-names>S</given-names></name><name><surname>Francis</surname><given-names>H</given-names></name><name><surname>Marucci</surname><given-names>L</given-names></name><name><surname>Benedetti</surname><given-names>A</given-names></name><name><surname>Alvaro</surname><given-names>D</given-names></name><name><surname>Taffetani</surname><given-names>S</given-names></name><name><surname>Ueno</surname><given-names>Y</given-names></name><name><surname>Roskams</surname><given-names>T</given-names></name><name><surname>Phinizy</surname><given-names>JL</given-names></name><name><surname>Venter</surname><given-names>J</given-names></name><name><surname>Fava</surname><given-names>G</given-names></name><name><surname>Lesage</surname><given-names>GD</given-names></name><name><surname>Alpini</surname><given-names>G</given-names></name></person-group><article-title>Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin</article-title><source>Gastroenterology</source><year>2005</year><volume>128</volume><fpage>121</fpage><lpage>137</lpage><pub-id pub-id-type="pmid">15633129</pub-id></citation></ref><ref id="B138"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moezi</surname><given-names>L</given-names></name><name><surname>Shafaroodi</surname><given-names>H</given-names></name><name><surname>Sarkar</surname><given-names>S</given-names></name><name><surname>Emami-Razavi</surname><given-names>SH</given-names></name><name><surname>Sanatkar</surname><given-names>M</given-names></name><name><surname>Mirazi</surname><given-names>N</given-names></name><name><surname>Dehpour</surname><given-names>AR</given-names></name></person-group><article-title>Involvement of nitrergic and opioidergic systems in the hypothermia induced by cholestasis in rats</article-title><source>Pathophysiology</source><year>2006</year><volume>13</volume><fpage>227</fpage><lpage>232</lpage><pub-id pub-id-type="pmid">16963238</pub-id></citation></ref><ref id="B139"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mombeini</surname><given-names>T</given-names></name><name><surname>Roushanzamir</surname><given-names>F</given-names></name><name><surname>Jorjani</surname><given-names>M</given-names></name><name><surname>Pourpak</surname><given-names>Z</given-names></name><name><surname>Gaskari</surname><given-names>SA</given-names></name><name><surname>Mehr</surname><given-names>SE</given-names></name><name><surname>Dehpour</surname><given-names>AR</given-names></name></person-group><article-title>Alteration in specific opioid-receptor labeling on peripheral blood leukocytes of bile duct-ligated rat</article-title><source>Pathophysiology</source><year>2006</year><volume>13</volume><fpage>111</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">16542827</pub-id></citation></ref><ref id="B140"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>L</given-names></name><name><surname>Vergnolle</surname><given-names>N</given-names></name><name><surname>D'Mello</surname><given-names>C</given-names></name><name><surname>Chapman</surname><given-names>K</given-names></name><name><surname>Le</surname><given-names>T</given-names></name><name><surname>Swain</surname><given-names>MG</given-names></name></person-group><article-title>Endogenous opioid-mediated antinociception in cholestatic mice is peripherally, not centrally, mediated</article-title><source>J Hepatol</source><year>2006</year><volume>44</volume><fpage>1141</fpage><lpage>1149</lpage><pub-id pub-id-type="pmid">16466825</pub-id></citation></ref><ref id="B141"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marzioni</surname><given-names>M</given-names></name><name><surname>Baroni</surname><given-names>GS</given-names></name><name><surname>Alpini</surname><given-names>G</given-names></name><name><surname>Benedetti</surname><given-names>A</given-names></name></person-group><article-title>Endogenous opioid peptides and chronic liver disease: from bedside to bench</article-title><source>J Hepatol</source><year>2007</year><volume>46</volume><fpage>583</fpage><lpage>586</lpage><pub-id pub-id-type="pmid">17313989</pub-id></citation></ref><ref id="B142"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bogorad</surname><given-names>RL</given-names></name><name><surname>Ostroukhva</surname><given-names>TY</given-names></name><name><surname>Orlova</surname><given-names>AN</given-names></name><name><surname>Rubtsov</surname><given-names>PM</given-names></name><name><surname>Smirnova</surname><given-names>OV</given-names></name></person-group><article-title>Long isoform of prolactin receptor predominates in rat intrahepatic bile ducts and further increases under obstructive cholestasis</article-title><source>J Endocrinol</source><year>2006</year><volume>188</volume><fpage>345</fpage><lpage>354</lpage><pub-id pub-id-type="pmid">16461560</pub-id></citation></ref><ref id="B143"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>L</given-names></name><name><surname>Begega</surname><given-names>A</given-names></name><name><surname>Arias</surname><given-names>JL</given-names></name><name><surname>Lorente</surname><given-names>L</given-names></name><name><surname>Aller</surname><given-names>MA</given-names></name><name><surname>Duran</surname><given-names>M</given-names></name><name><surname>Arias</surname><given-names>J</given-names></name></person-group><article-title>Hepatic cytochrome oxidase in rats with microsurgical cholestasis or portocaval shunt</article-title><source>Rev Esp Enferm Dig</source><year>1999</year><volume>91</volume><fpage>365</fpage><lpage>373</lpage><pub-id pub-id-type="pmid">10362878</pub-id></citation></ref><ref id="B144"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wong-Riley</surname><given-names>MTT</given-names></name></person-group><article-title>An endogenous metabolic marker for neuronal activity</article-title><source>Trends Neurosci</source><year>1989</year><volume>12</volume><fpage>94</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">2469224</pub-id></citation></ref><ref id="B145"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Georgiev</surname><given-names>P</given-names></name><name><surname>Jochum</surname><given-names>W</given-names></name><name><surname>Heinrich</surname><given-names>S</given-names></name><name><surname>Jang</surname><given-names>JH</given-names></name><name><surname>Nocito</surname><given-names>A</given-names></name><name><surname>Dahm</surname><given-names>F</given-names></name><name><surname>Clavien</surname><given-names>PA</given-names></name></person-group><article-title>Characterization of time-related changes after experimental bile duct ligation</article-title><source>Br J Surg</source><year>2008</year><volume>95</volume><fpage>646</fpage><lpage>656</lpage><pub-id pub-id-type="pmid">18196571</pub-id></citation></ref><ref id="B146"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gehring</surname><given-names>S</given-names></name><name><surname>Dickson</surname><given-names>EM</given-names></name><name><surname>San Martin</surname><given-names>ME</given-names></name><name><surname>Van Rooijen</surname><given-names>N</given-names></name><name><surname>Papa</surname><given-names>EF</given-names></name><name><surname>Harty</surname><given-names>MW</given-names></name><name><surname>Tracy</surname><given-names>TF</given-names></name><name><surname>Gregory</surname><given-names>SS</given-names></name></person-group><article-title>Kupffer cells abrogate cholestatic liver injury in mice</article-title><source>Gastroenterology</source><year>2006</year><volume>130</volume><fpage>810</fpage><lpage>822</lpage><pub-id pub-id-type="pmid">16530521</pub-id></citation></ref><ref id="B147"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Mizuno</surname><given-names>S</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name></person-group><article-title>Antinecrotic and antipoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases</article-title><source>Am J Physiol Gastrointest Liver Physiol</source><year>2007</year><volume>292</volume><fpage>G639</fpage><lpage>G646</lpage><pub-id pub-id-type="pmid">17068118</pub-id></citation></ref><ref id="B148"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Zheng</surname><given-names>G</given-names></name><name><surname>Dillard Iii</surname><given-names>B</given-names></name><name><surname>Tallarico</surname><given-names>M</given-names></name><name><surname>Ortiz</surname><given-names>Z</given-names></name><name><surname>Holterman</surname><given-names>AX</given-names></name></person-group><article-title>Transcriptional activation by growth hormone of HNF-6-regulated hepatic genes, a potential mechanism for improved liver repair during biliary injury in mice</article-title><source>Am J Physiol Gastrointest Liver Physiol</source><year>2008</year><volume>295</volume><fpage>G357</fpage><lpage>G366</lpage><pub-id pub-id-type="pmid">18511741</pub-id></citation></ref><ref id="B149"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoekstra</surname><given-names>H</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Jocum</surname><given-names>W</given-names></name><name><surname>Stieger</surname><given-names>B</given-names></name><name><surname>Graf</surname><given-names>R</given-names></name><name><surname>Porte</surname><given-names>RJ</given-names></name><name><surname>Clavien</surname><given-names>PA</given-names></name></person-group><article-title>Dearterialization of the liver causes intrahepatic cholestasis due to reduced bile transporter expression</article-title><source>Transplantation</source><year>2008</year><volume>85</volume><fpage>1159</fpage><lpage>1166</lpage><pub-id pub-id-type="pmid">18431237</pub-id></citation></ref><ref id="B150"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Semenza</surname><given-names>GL</given-names></name></person-group><article-title>Targeting HIF-1 for cancer therapy</article-title><source>Nat Rev Cancer</source><year>2003</year><volume>3</volume><fpage>721</fpage><lpage>732</lpage><pub-id pub-id-type="pmid">13130303</pub-id></citation></ref><ref id="B151"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Lazaro</surname><given-names>M</given-names></name></person-group><article-title>HIF-1: hypoxia-inducible factor or dysoxia-inducible factor?</article-title><source>FASEB J</source><year>2006</year><volume>20</volume><fpage>828</fpage><lpage>832</lpage><pub-id pub-id-type="pmid">16675839</pub-id></citation></ref><ref id="B152"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brunengraber</surname><given-names>H</given-names></name><name><surname>Roe</surname><given-names>CR</given-names></name></person-group><article-title>Anaplerotic molecules: current and future</article-title><source>J Inherit Metab Dis</source><year>2006</year><volume>29</volume><fpage>327</fpage><lpage>331</lpage><pub-id pub-id-type="pmid">16763895</pub-id></citation></ref><ref id="B153"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deberardinis</surname><given-names>RJ</given-names></name><name><surname>Mancuso</surname><given-names>A</given-names></name><name><surname>Daikhin</surname><given-names>E</given-names></name><name><surname>Nissim</surname><given-names>I</given-names></name><name><surname>Yudkoff</surname><given-names>M</given-names></name><name><surname>Wehrli</surname><given-names>S</given-names></name><name><surname>Thompson</surname><given-names>CB</given-names></name></person-group><article-title>Beyond aerobic glycolysis: transformed cells can engage in glutamine metbolism that exceeds the requirement for protein and nucleotide synthesis</article-title><source>Proc Natl Acad Sci USA</source><year>2007</year><volume>104</volume><fpage>19345</fpage><lpage>19350</lpage><pub-id pub-id-type="pmid">18032601</pub-id></citation></ref><ref id="B154"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marcel</surname><given-names>M</given-names></name><name><surname>Leroy</surname><given-names>A</given-names></name></person-group><article-title>Clinical, cellular and molecular aspects of cancer invasion</article-title><source>Physiol Rev</source><year>2003</year><volume>83</volume><fpage>337</fpage><lpage>376</lpage><pub-id pub-id-type="pmid">12663862</pub-id></citation></ref></ref-list></back></article>